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FraCTureS
A fracture is defined as a local separation of an object or material into two or 
more pieces or fragments under the action of an external stress. Although frac-
tures are occurring throughout life, most fractures occur after the age of 50. The 
yearly fracture incidence in women and men in this age group in the Netherlands 
approximates 80,0001.  The remaining life-time risk of sustaining a fracture in 
Caucasian women older than 50 years is >50% and of Caucasian men >20% 2. 
This burden of fractures leads to an increase in morbidity, mortality, re-fracture 
risk and healthcare costs. Especially the occurrence of a hip fracture is associated 
with loss of independence, higher morbidity, mortality and subsequent fracture 
risk3, 4. Moreover, the number of fractures is expected to increase mainly due 
to the world’s ageing population5. Besides the health impact on the individual 
patient, the socioeconomic burden of fractures is substantial. Therefore, it is es-
sential to optimize the evaluation and treatment of each fracture patient and 
concordantly to reduce subsequent fracture incidence. 
Vertebral versus non-vertebral fractures 
At the Emergency Departments (ED) throughout the Netherlands 95% of all 
fractures are non-vertebral fractures1. This is quite remarkable, as radiographic 
vertebral fractures are the most frequent fractures after the age of 50 years in 
women and in men2. However, only one in three radiographic vertebral fractures 
come to clinical attention with the clinical signs and symptoms of an acute frac-
ture and they can occur without trauma or fall6. Even when the clinical expression 
of a vertebral fracture is acute or chronic back pain, or imaging of the spine is 
available, they are often overlooked7. Lastly, due to the subclinical course of most 
vertebral fractures, it is most often not possible to specify the exact timing when 
the vertebral fracture occurred.
In contrast, non-vertebral fractures are easily diagnosed (with the exception 
of some stress fractures). The consequence is that patients with a non-vertebral 
fracture are clinically easily identifiable; that radiographic confirmation is simple 
in most cases and that the exact timing of the fracture is known. In addition, non-
vertebral fractures are major contributors to the cost of acute fracture care8-11. 
Because non-vertebral fractures are the most frequent in ED, are clinically and 
radiographically easily identifiable in terms of location and timing and are costly, 
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we concentrate in this thesis on patients with a first or repeat non-vertebral 
fracture. 
Timing of fractures
The risk of sustaining a subsequent fracture is double of sustaining a first fracture 
after the age of 50 years, but this risk increase is not constant over time12, 13. The 
highest risk is within the first years following the fracture, while the hazard de-
creases gradually over time14.  This has been shown for repeat radiographic and 
clinical vertebral fractures, for repeat hip fractures and for any repeat non-verte-
bral fractures14-21. This implicates that there might be a window of opportunity 
shortly after the first fracture to intervene in order to diminish the re-fracture risk. 
THe FraCTure LIaISon SerVICe
There is a growing interest among orthopedic and trauma surgeons in patients 
with a recent clinical fracture to not only focus on fracture treatment by a 
cast or surgery, but also on bone- and fall- related fracture risk evaluation and 
treatment. A Fracture Liaison Service (FLS) is one of the initiatives in the field 
of post-fracture care to integrate risk evaluation and secondary prevention in 
fracture patients 22-25, and is considered the most effective strategy to maximize 
the implementation of diagnostic and therapeutic decisions for secondary frac-
ture prevention.26-28 In the Netherlands, many FLSs are managed by a fracture 
nurse who coordinates and examines all patients who are able and willing to 
participate, according to the guidelines on osteoporosis and fracture prevention 
and on fall prevention and are supervised by an endocrinologist, rheumatologist 
or surgeon 23, 24, 29. 
risk evaluation at the FLS
The risk of fractures is multifactorial. In general, the risk factors for fractures can 
be divided into risk factors that contribute to bone fragility (such as osteoporo-
sis), to extraskeletal factors that increase the risk of trauma, mostly falls (such as 
sarcopenia) or to a combination of both (e.g. age). 
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Figure 1 Risk factors for hip fracture 
 
Factors related to bone fragility 
Bone is a complex organ, consisting of cortical bone, that contributes to its stiffness, and of 
trabecular bone, that contributes to its flexibility. It is a composite material, consisting of 
layers of collagen fibers, calcium-phosphate crystals (hydroxy-apatite) and proteins (such as 
growth factors). This composite material is continuously remodeled during life by the bone 
cells, which consist of osteoclasts, osteoblasts, osteocytes and lining cells. Bone cells 
communicate with each other and with systemic factors. As a result, in young healthy 
subjects, bone is strong, yet light, stiff, yet flexible, and as such quoted as optimal bone 
quality30. 
Of the factors that contribute to bone quality are its mass and density, which can be 
measured by bone densitometry using DXA. For each decrease in 1 Standard Deviation (SD) 
in BMD, the risk of fractures is doubled. For epidemiological purposes, the World Health 
Organization (WHO) defined osteoporosis as a systemic disease, characterized by low bone 
mass microarchitecturial disruption, resulting in an increased risk of fractures 31. 
Osteoporosis was defined as a BMD below a T-score of -2.5, and severe osteoporosis in the 
presence of a T-score of <-2.5 and a fracture32. However, most patients with a recent 
fracture do not have osteoporosis at time of the fracture according to this definition33, 34, 
even in elderly older than 80 years with a hip fracture33.  
Therefore BMD alone is not sufficient to provide an accurate prediction of fracture risk. 
Other clinical, non-BMD risk factors are known to be important for estimating an adequate 
probability of fracture risk as well35, 36, and several of these risk factors contribute to both 
bone fragility and fall risk. 
Figure 1. Multifactorial etiology o  (hip) fractures
Factors related to bone fragility 
Bone is a complex organ, consisting of cortical bone, that contributes to its stiff-
ness, and of trabecular bone, that contributes to its flexibility. It is a composite 
material, consisting of layers of collagen fibers, calcium-phosphate crystals 
(hydroxy-apatite) and proteins (such as growth factors). This composite material 
is continuously remodeled during life by the bone cells, which consist of osteo-
clasts, osteoblasts, osteocytes and lining cells. Bone cells communicate with each 
other and with systemic factors. As a result, in young healthy subjects, bone is 
strong, yet light, stiff, yet flexible, and as such quoted as optimal bone quality30.
Of the factors that contribute to bone quality are its mass and density, which 
can be measured by bone densitometry using DXA. For each decrease in 1 
Standard Deviation (SD) in BMD, the risk of fractures is doubled. For epidemio-
logical purposes, the World Health Organization (WHO) defined osteoporosis as 
a systemic disease, characterized by low bone mass microarchitecturial disrup-
tion, resulting in an increased risk of fractures 31. Osteoporosis was defined as a 
BMD below a T-score of -2.5, and severe osteoporosis in the presence of a T-score 
of <-2.5 and a fracture32. However, most patients with a recent fracture do not 
have osteoporosis at time of the fracture according to this definiti n33, 34, even in 
elderly older than 80 years with a hip fracture33. 
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Therefore BMD alone is not sufficient to provide an accurate prediction of 
fracture risk. Other clinical, non-BMD risk factors are known to be important for 
estimating an adequate probability of fracture risk as well35, 36, and several of 
these risk factors contribute to both bone fragility and fall risk.
A history of any fracture predisposes for sustaining a subsequent fracture. Spe-
cifically, a non-vertebral fracture is associated with a doubling of the risk of a sub-
sequent fracture, while this risk is quadrupled after a vertebral fracture1, 12, 13, 19, 37. 
Other known clinical risk factors which increase fracture risk are age, female gen-
der, family history of a hip fracture in the parents, immobility, low body weight 
(<60 kg), underlying diseases, medications (e.g. glucocorticosteroids), smoking 
and excessive alcohol intake 1, 37. In 2011 the WHO developed and launched a 
Fracture Risk Assessment tool (FRAX Ó) to evaluate the 10-year fracture risk of 
patients. In the FRAX clinical risk factors, with or without a BMD, predict the 10-
year probability of a major or hip fracture for an individual patient38. The FRAX 
does not include evaluation of fall risk, or the number of prior falls and fractures, 
which are actually included in the Garvan Fracture Risk Calculator39.  This Garvan 
calculator gives higher estimates for fracture risk then FRAX in patients with a 
history of falls and multiple fractures40. Both internet-based tools are freely avail-
able, easy to use for professionals and helpful in calculating the absolute fracture 
risk in an individual.
Fall-related risk factors 
Each year, more than one-third of all people aged 65 years and older fall, of whom 
50% are repeat fallers41. Furthermore, approximately one out of ten falls results 
in serious injury such as a fracture, hematoma or head injury. Moreover, of all 
ED visits of elderly 80-90% is due to a fall42. Risk of falling is also multifactorial of 
origin and associated with age, female gender, other health conditions such as 
arthritis, depressive symptoms, impairment in cognition and/or vision, balance 
gait, orthostatic hypotension, impairment of muscle strength (sarcopenia), poly-
pharmacia (>4 prescript medications) and urinary incontinence 41, 43, 44 . 
Fracture prevention strategies
In order to prevent fractures, guidelines have been developed that focused on 
protecting or increasing bone quality (as proved by a reduction in fracture risk) 
and focused on non-skeletal factors in order to decrease the risk of falls.
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In RCTs, many drugs have been shown to reduce the risk of vertebral fractures 
by 40-80% and for hip fractures by 33%. In contrast, the risk reduction in non-
vertebral fractures is less pronounced, for anti-resorptives, in the order of 25% in 
a recent meta-analysis45. In general, guidelines advocate drugs that have been 
proven to have a broad spectrum of fracture reduction (preventing vertebral, 
non-vertebral and hip fractures) as a first choice in high-risk patients, together 
with sufficient calcium intake and vitamin D supplements. In the context of 
secondary fracture prevention, all guidelines advocate bone risk evaluation and 
drug treatment in high-risk patients. Recent data suggest that not only fractures 
but also mortality is decreased with the use of (oral and intravenous) bisphos-
phonates (BPs) for osteoporosis 33, 46-51. The mechanisms seem to be multifactorial 
and are probably related to extra skeletal effects of BPs49. A small proportion of 
the reduction in mortality is due to prevention of subsequent fractures33.
In RCTs on fall prevention, a multifactorial falls risk assessment and management 
programme as well as exercise programme has been shown to reduce the risk 
of falls by 14-18%52. However, until today, no fall prevention study has shown a 
fracture reduction by reducing falls52, 53. Guidelines on fall prevention advocate 
that all 50+ patients with a recent fracture should have a fall risk evaluation in 
order to reduce the risk of a subsequent fall. 
STudy deSIgn
We followed for 5-years a cohort of fracture patients of ≥50 years with a recent 
non-vertebral fracture treated at the Maastricht University Medical Centre, the 
Netherlands, between 1999 and 2001. A different cohort of patients ≥50 years with 
a recent non-vertebral fracture were evaluated, treated and followed for 2-years 
at the Fracture Liaison Service in the same hospital between 2004 and 2006. All 
patients were followed for 2-years for occurrence of subsequent non-vertebral 
fractures or mortality. To be able to do a cross over study a fracture patient cohort 
of the VieCuri Medical Centre Venlo, The Netherlands, was followed in the similar 
study period of 2004-2006. With these fracture cohorts we were able to do a pre- 
versus post- FLS analyses.
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aIM and ouTLIne oF CurrenT THeSIS
The aim of the current thesis was first to evaluate the level of risk for subsequent 
non-vertebral fractures and mortality in 50+ patients with a recent non-vertebral 
fracture in relation to the presence of risk factors. Second, we compared the re-
fracture and mortality risk in hospitals with and without FLS and before and after 
the introduction of the FLS in the same hospital. Third, the implementation of the 
Dutch guideline on osteoporosis and fracture prevention was evaluated in 5 FLSs 
in the Netherlands. 
In the first chapter a general introduction into the field is given with the thesis 
outline and its aims. The second chapter focuses on defining the 5-year subse-
quent non-vertebral fracture risk and mortality in 50+ with a recent non-vertebral 
fracture. The third chapter examines the timing of subsequent fractures over 
time. The scope of the fourth chapter is on bone- and fall related risk factors 
in patients with a recent non-vertebral fracture regarding subsequent fracture 
incidence and mortality. The fifth chapter describes five FLSs throughout the 
Netherlands and their implementation of osteoporosis guidelines. In the sixth 
chapter, a comparison is made between patients treated at a FLS and patients 
who received usual care on subsequent non-vertebral fracture incidence and 
mortality. In the seventh chapter the benefit of a FLS in fracture patients was 
evaluated between a hospital with and a hospital without a FLS, focused on 
subsequent non-vertebral fracture incidence and mortality. The eight and last 
chapter of this thesis encompasses a summary and conclusions and some future 
perspectives.
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aBSTraCT
Introduction
Non-vertebral fractures (NVFs) are the most frequent clinical fractures in patients 
presenting at the emergency unit because of a clinical fracture. The aim of the 
study was to determine the 5-year absolute risk (AR) of subsequent NVF and 
mortality in patients at the time they present with a NVF.
Methods
Between 1999 and 2001, 1921 consecutive patients 50+ years from a level-one 
trauma centre were included. All NVFs were confirmed on radiograph reports 
and mortality was checked in the national obituary database. Available potential 
risk factors for a subsequent NVF and mortality (age, sex and baseline fracture 
location: major: hip, pelvis, multiple ribs, proximal tibia/humerus, distal femur; 
minor: all other) were expressed as hazard ratio’s (HR) with 95% confidence inter-
vals (CI) using multivariable Cox regression analysis. 
results
The AR for a subsequent NVF was 17.6% and was related to age (HR per 
decade:1.44;95%CI:1.29-1.60). The AR for mortality was 32.3% and was related 
to age (HR per decade:2.59;95%CI:2.37-2.84), male sex (HR:1.74;95%CI:1.44-2.10), 
major fracture at baseline (HR:5.56;95%CI:3.48-8.88;not constant over time) 
and subsequent fracture (HR:1.65;95%CI:1.33-2.05). The highest risks were found 
within the first year (NVFs: 6.4%, mortality: 12.2%) and were related to age, and in 
addition, to baseline fracture location for mortality.
Conclusions
Within 5 years after an initial NVF, nearly one in five patients sustained a subse-
quent NVF and one in three died. One third of subsequent NVFs and mortality 
occurred within one year, indicating the need to study which reversible factors 
can be targeted to immediately prevent subsequent fractures and mortality.
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InTroduCTIon
A history of non-vertebral fracture (NVF) is associated with a doubling of the risk 
of a subsequent fracture, and the subsequent fracture risk is quadrupled after a 
vertebral fracture 1, 2. This subsequent fracture risk is not constant over time and is 
driven by the high, 3- to 5-fold increase in the years immediately after a first frac-
ture, followed by a gradual waning off later on 3. This has been shown for repeat 
morphometric vertebral fractures 4, subsequent clinical spine, forearm and hip 
fractures in patients who were hospitalised with a vertebral fracture 5, repeat low 
trauma fractures in subjects older than 60 years 6, repeat clinical vertebral and 
non-vertebral fractures from menopause onwards 3, 7, 8 and repeat hip fractures 
9. As a result, it has been shown in long-term follow up studies that 40 to 50% of 
all subsequent fractures occur within 3 to 5 years after a first fracture. The clinical 
implication is that patients older than 50 years presenting with a fracture need 
immediate attention to reduce reversible risk factors of a subsequent fracture. 
This indicates to undertake immediate care in fracture patients is necessary, such 
as the Fracture Liaison Service, the involvement of a fracture nurse and other 
initiatives in the field of post-fracture care 10-13. It also indicates that treatment, 
which has been shown to reduce fracture risk within short term, should be 
started as soon as possible in patients with a high fracture risk 14.
An increased risk of mortality has been documented after hip, vertebral and 
several non-hip-non-vertebral fractures 15. Similar to subsequent fracture risk, 
this increase in mortality is higher immediately after fracture than later on. In 
women and men older than 60 years, nearly 90% of excess deaths related to 
fracture over the 18 years of observation occurred in the first 5 years. 
Of the 5-year post-fracture excess mortality, approximately one-third of deaths 
were associated to hip, vertebral, and non-hip-non-vertebral fractures, respec-
tively. The major causes of death were related to cardiovascular and respiratory 
co-morbidity and infections 15. 
NVFs are the most frequent fractures in patients presenting at the emergency 
unit because of a clinical fracture 8. There is therefore an increasing interest on the 
role of drug intervention to reduce the risk of NVFs 16 and subsequent mortality 17. 
To our knowledge, this is the first study analyzing all consecutive patients older 
than 50 years of age presenting with a NVF during a 5 year follow-up. The aim of 
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the present study was to determine the 5-year absolute risk (AR) of subsequent 
NVF and mortality after a NVF. 
MaTerIaLS and MeTHodS
recruitment of patients
In this retrospective study, the hospital database code (ICD9) for fractures was 
used to recruit patients. All fractures reported in the patients’ medical files were 
radiographically confirmed. Only subsequent fractures that are reported in the 
same hospital database were used for the follow-up analyses. Whether patients 
were deceased during follow-up was confirmed using the national obituary 
database. Inclusion criteria for this study were the following: 1/ age ≥ 50 years; 
2/ a recent non- vertebral fracture (NVF) between January 1999 and December 
2001; and 3/ living in the postal code area of Maastricht. Patients were excluded 
if they had sustained a pathological fracture. Vertebral fractures were not taken 
into consideration. The International Classification of Disease (ICD-9) was used to 
classify clinical fractures into 15 categories: skull, vertebra, clavicle, thorax, pelvis, 
humerus, forearm, wrist, hand, hip, femur, patella, tibia/fibula, ankle or foot. 
These fractures were further analysed according to fracture location (humerus, 
wrist, hip) and grouping of several locations: other, multiple simultaneous, frac-
tures belonging to the 6 main NVFs (wrist, leg, humerus, hip, pelvis or clavicle) 
or not 16and into major fractures (hip, pelvis, proximal tibia or humerus, multiple 
ribs and distal femur) and minor fractures (all other fractures) 18. All groups are 
mutually exclusive and included all patients.
Available potential risk factors for subsequent fracture and mortality included 
age, sex and baseline fracture locations 6, 15. In this paper we only showed the 
Kaplan Meier and Cox regression analyses with major vs. minor fractures as 
baseline fracture location. To create table 1 we used the other classifications as 
mentioned above. 
Statistical analysis
Univariable Kaplan-Meier curves, univariable, multivariable and time-dependent 
Cox regression analyses were performed to determine the contribution of risk 
factors (age, sex and location of the baseline fracture) to the incidence of subse-
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quent NVFs and mortality. Follow-up time was defined as time between first frac-
ture and subsequent fracture, death or end of the study period of 5 years. With 
respect to mortality the follow-up time was defined as time between first fracture 
and death or end of the study period. Hazard Ratios (HR) and 95% Confidence 
intervals (95% CI) were reported. Two-tailed P <0.05 was considered significant.
The Schoenfeld residuals were used to check the assumptions of proportionality. 
If violated, then we used the time-dependent Cox regression analysis to repre-
sent the profile of the HR over time. Linearity was checked for age. SPSS 15.0 for 
windows (SPSS Inc., Illinois, USA) was used to process the data. 
reSuLTS
A total of 1921 patients aged over 50 years were included, 1433 women and 488 
men. Women were significantly older than men (women: 73.5 ± 11.5 years and 
men 67.1 ± 12.2 years, P<0.001). The majority of the baseline fractures occurred at 
the ulna/radius (number of patients = 502; 26.1%), hip (number of patients = 469; 
24.4%) and other (number of patients = 561; 29.2%) (Table 1).
The patients can be categorized in the following four groups: patients who died 
without (n=509) or after a subsequent NVF (n=111) and patients still alive after 5 
Baseline fracture location Men
n=488
(%)
Women
n= 1433
(%)
all
n=1921
(%)
Humerus 38 (7.8) 184 (12.8) 222 (11.6)
Wrist 69 (14.1) 433 (30.2) 502 (26.1)
Hip 115 (23.6) 354 (24.7) 469 (24.4)
other 203 (41.6) 358 (25.0) 561 (29.2)
Multiple 63 (12.9) 104 (7.3) 167 (8.7)
6 main nVFs 341 (69.9) 1211 (84.5) 1552 (80.8)
no main nVFs 147 (30.1) 222 (15.5) 369 (19.2)
Major 214 (43.9) 651 (45.4) 865 (45.0)
Minor 274 (56.1) 782 (54.6) 1056 (55.0)
Table 1.
Patients according to baseline fracture location
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years of follow-up with (n=227) or without a subsequent NVF (n=1074) (Figure 1), 
during a total of 7685 patient-years. Clearly, the most common outcome 5 years 
after a NVF is to be  alive without a subsequent fracture (in 55.9% of patients)
(Figure 1).
Subsequent fractures
During the 5-year follow-up period, 338 patients had 379 subsequent NVFs, indi-
cating an absolute risk (AR) of 17.6% (95% CI: 15.9-19.3) (Table 2). 
In univariable analysis, women sustained significantly more subsequent frac-
tures than men (19.3% vs. 12.7%, P=0.001;HR: 1.54; 95% CI: 1.17-2.03). Also increasing 
age (HR per decade: 1.49; 95% CI: 1.36-1.64) and major baseline fracture location 
(HR 1.60; 95% CI: 1.29-1.98) contributed in univariable analysis to subsequent 
fracture risk. (Figure 2).
Hazard ratio’s were similar when baseline finger and toe fractures were ex-
cluded in the analysis (data not shown). In multivariable analysis only age (HR 
per decade:1.44; 95% CI: 1.29-1.60) remained a significant contributor. 
Mortality 
During 5 year follow-up a total of 620 patients died, indicating an AR of 32.2% 
(95%CI: 30.1-34.3). This number consisted of 468 (32.7%) women and 152 men 
(31.1%). Univariable analysis showed a significant contribution of age and baseline 
fracture location to mortality incidence (P<0.001; Figure 2). To evaluate whether 
patients with a subsequent fracture had an increased risk on mortality compared 
with patients without a subsequent fracture, we used the time dependent Cox 
Figure 1  
Flow chart of patients included in the study 
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regression analysis. This showed, in univariable analysis, an association (HR 2.48 
95% CI: 2.00-3.07) between patients with a subsequent fracture and mortality 
compared with patients without a subsequent fracture.
In multivariable analysis, the incidence of mortality was higher in men (HR: 1.74; 
95%CI: 1.44-2.10) compared with women, corrected for age and baseline fracture 
location. The HR of baseline fracture location (major/minor) was not consistent 
over time. Using time dependent Cox regression, immediately after the baseline 
fracture, HR was 5.56 (95% CI:3.48-8.88) and declined at 37 months follow-up to 
HR 1.27 (95% CI: 0.97-1.66; p=0.077) and increased slightly thereafter to approxi-
mately the HR at 12 months (Table 2). Overall results of Cox regression showed 
that age, male gender, a major fracture and a subsequent fracture at baseline 
were independent risk factors for mortality (Table 2).
Timing of subsequent nVF and mortality
Risk of subsequent NVF and mortality significantly changed over time (Figure 4). 
The AR for subsequent NVF was 6.4% and progressively decreased to 3.3% in the 
5th year (Figure 3). 
Of all the patients with a subsequent NVF, 36.4% sustained a NVF within in the 
first year. Clustering of fractures was found at all ages, in women and men and in 
all subgroups of fractures. 
Variable Hazard ratio 95% CI P-value
Sex
Men vs. women 1.74 1.44-2.10 <0.001
age (per decade) 2.59 2.37-2.84 <0.001
Baseline fracture location
(major vs. minor)
0 months 5.56 3.48-8.88 <0.001
12 months 2.44 1.90-3.14 <0.001
24 months 1.49 1.13-1.96 0.004
36 months 1.27 0.97-1.66 0.083
48 months 1.50 1.14-1.97 0.004
60 months 2.47 1.41-4.33 0.002
Patients with a subsequent 
fracture vs. patients without a 
subsequent fracture
1.65 1.33-2.05 <0.001
Table 2.
Mortality incidence: Multivariable Cox regression analysis with time-dependent covariates
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The incidence of mortality was highest in the first year following the baseline 
fracture (12.2%) and declined to 6.9% in the fifth year (Figure 3). Of all subsequent 
mortality, 37.9% occurred within the 1st  year. Of the patients who sustained a hip 
fracture, the 1-year mortality was 40% in men and 29% in women. At the end 
of the follow-up period 302 (65%) of the hip fracture patients at baseline were 
deceased. 
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dISCuSSIon
Based on hospital databases for radiographically diagnosed fractures to ascer-
tain fractures and the national obituary, the AR of sustaining a new NVF within 
five years after a NVF was 17.6% and 32.3% for mortality. Until today, there have 
not been data published regarding subsequent fracture risk and mortality in a 
patient population with all clinical fractures (NVF) of 50 years and over with a five 
year follow-up period. Moreover, there are no guidelines which recommend to 
evaluate all these patients we investigated in this research.
Remarkably, after multivariable analysis patients sustaining a minor fracture 
had a similar risk to a subsequent fracture as patients with a major fracture at 
baseline, even after a hip fracture. In addition, the same was true between sexes: 
after correction for age subsequent fracture rate was similar between men and 
women, as found by Center 6. Even patients with a wrist fracture at baseline 
had an AR of a subsequent fracture of 17.9% within 5 years follow-up. From a 
clinical point of view these results indicate that fracture prevention should be 
considered after any fracture. Increasing age was the most important factor for a 
subsequent fracture corrected for sex and baseline fracture location. Only three 
variables (age, gender and fracture location) were available and not surprisingly 
age was the most predictive factor as in most other fracture prediction models. 
Over one third (36.4%) of the patients sustained a subsequent NVF within the first 
year after their baseline fracture. Previous studies reported similar findings. In our 
own previous study we found an absolute risk of 10.8% for sustaining any clinical 
subsequent fracture within 2 years after baseline fracture, with 60% occurring 
in the first year after the baseline fracture 8. Van Geel et al. found a RR of 5.3 of 
subsequent fracture compared with patients without a subsequent fracture 3
Similar results were reported after vertebral fractures 19. Center et al. showed 
that 41% of the women and 52% of the men sustained their subsequent fracture 
within the first two years after the initial fracture. The aim of this study was not 
to compare subsequent fracture incidence with first fracture incidence, as we 
already have shown in a population based study in post menopausal women be-
tween age 45 and 90 years old from the same region, that the one year incidence 
of all first fractures was 1.0%. We recalculated the risk of only a first NVF, which was 
0.9% (excluding all patients with vertebral fractures). In that study the first year 
subsequent fracture incidence was 6.0 % almost equal as in our study (6.8%)3.
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During the study almost one in three patients died. Our results confirm pre-
vious findings by others that mortality is associated with increasing age, male 
gender and baseline fracture location in a multivariable model, even at the age 
of 50 years and over 15, 18, 20-27. 
There are some potential limitations to this study. First, due to the retrospec-
tive design of this study, we could have missed subsequent fractures, which had 
occurred outside the recruitment region of the hospital. In an earlier study less 
than 1% of all patients presenting at the Emergency Department were from out-
side the hospital region indicating that less than 1% of fractures could have been 
missed 8. All fractures in the hospital are coded (ICD-9) and stored in the hospital 
database. Second, vertebral fractures were excluded because of difficulty with 
verification of timing of these fractures. Third, we have no data on the trauma 
mechanism. In earlier studies we have shown that about 20% of clinical fractures 
are not resulting from a fall from maximum standing height or lesser trauma 28. 
However, Mackay et al. has shown that the risk of subsequent fractures is similar 
after high and low energy trauma 29. There are no data available for mortality 
after high and low energy trauma in fractures.
Fourth, there are no data on the cause of death. We therefore can not correlate 
if these deaths are directly related to the previous fracture or the subsequent 
fracture. The enhanced mortality could be a sign of poor health or other underly-
ing conditions. Further studies will be necessary to examine to what degree bone 
and extraskeletal risks are predictive for subsequent fractures and mortality. 
Others have shown that bone, fall and general health related factors could be 
involved 15.
In conclusion, we found that within 5 years after an initial NVF, nearly one in 
five patients sustained a subsequent NVF and one in three died. One third of 
subsequent NVFs and mortality occurred within one year, indicating the need 
to study which reversible factors can be targeted to immediately prevent subse-
quent fractures and mortality.
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aBSTraCT
A prior fracture is a well documented risk factor for a subsequent fracture and it 
doubles the risk of subsequent fractures. Few studies have investigated the time 
that elapses between the initial and subsequent fracture. These studies show 
that the subsequent fracture risk is not constant, but fluctuates over time. The 
risk of subsequent vertebral, hip and non-vertebral non-hip fractures is highest 
immediately after initial hip, clinical and radiographic vertebral fractures and 
non-vertebral fractures and declines afterwards, regardless of gender, age and 
initial fracture location. These studies all indicate the need for early action after 
an initial fracture with medical interventions that have an effect within a short-
term to reduce the preventable risks of subsequent fractures. 
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InTroduCTIon
In terms of fractures, osteoporosis is one of the leading health problem in de 
Western world according to the World Health Organisation (WHO) and is a grow-
ing problem due to the ageing population 1, 2. However, in terms of BMD T-score 
<-2.5, osteoporosis is only one of the many risk factors for fractures 
A prior fracture is yet another well known risk factor for a subsequent fracture, 
independent of BMD 3. The risk of a subsequent fracture is doubled in the pres-
ence of a prior fracture (pooled relative risk (RR) of 2.0) 3. 
However, several studies have shown that the risk of subsequent fracture is not 
constant over time, but fluctuates over time, being highest immediately after the 
initial fracture 4-8. 
One of the earliest studies on the timing between first and subsequent fractures 
focused on patients who had been hospitalized because of a clinical vertebral 
fracture and in whom the risk of all subsequent fractures was highest within the 
first year following hospitalization for vertebral fracture in both women and men. 
Lindsay et al (2001) found that within one year after an incident radiographic 
vertebral fracture, 20% of patients had a new radiographic vertebral fracture 7.
These observations had a growing impact on further research on timing of 
subsequent fractures in relation to a first fracture, and focused on all fractures or 
specific initial or subsequent fracture locations. Indeed, if subsequent fractures 
cluster in time, this has as a clinical consequence the need for immediate atten-
tion for fracture patients in order to decrease the risk of subsequent fracture. 
Furthermore, if fractures cluster in time, algorithms for case finding should take 
into account the variable risk of subsequent fracture over time.
Several studies have meanwhile studied the time relation between fractures. 
However, the time relation between fractures has been reported in several ways 
in terms of relative risk (RR), absolute risk (AR), as percentages of all subsequent 
fractures that occurred over short and long term follow up, and as survival or cu-
mulative curves. First and subsequent fractures were studied at variable fracture 
locations (vertebral, non-vertebral, major, minor and hip fractures).
We reviewed these aspects in the literature on studies that reported the time 
relation between fractures and, as far as reported, review the RR, AR and percent 
of subsequent fractures, according to baseline and subsequent fracture location.
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CLuSTerIng In TIMe oF FraCTureS aFTer a VerTeBraL 
FraCTure
Morphometric vertebral fractures are the most frequent osteoporosis-related 
fractures, but only around one third come to clinical attention with the classical 
signs and symptoms of an acute fracture. Therefore, studies on vertebral fractures 
differ in including only clinical vertebral fractures or in systematic performance of 
radiographs of the thoracic and lumbar spine. 
repeat morphometric vertebral fractures
Only one study is available on repeat radiographic vertebral fractures and was 
performed by analyzing placebo-treated patients (n=2725), pooled from several 
fracture studies with risedronate 8. These women had either prevalent vertebral 
fractures 9, 10 low femoral neck BMD, or risk factors for hip fracture 11. All subjects 
received calcium supplementation (1000 mg/d). Women with serum 25-hy-
droxyvitamin D levels of less than 16 ng/mL (40 nmol/L) at baseline also received 
vitamin D supplementation (up to 500 IU/d).
In this study, the one-year incidence of radiographic vertebral fractures could 
be analysed in three groups of patients: 1/ patients without a prevalent fracture, 
2/ patients with a prevalent radiographic vertebral fracture before the start of the 
follow up, and of which the timing of the previous radiographic vertebral fracture 
was unknown, and 3/ patients who developed a new radiographic vertebral 
fracture during the study and who were followed yearly for the development of 
subsequent radiographic vertebral fractures. 
The cumulative incidence of new radiographic vertebral fractures in the first 
year of the study follow up (i.e. the AR for new radiographic vertebral fractures in 
patients with and without previous radiographic vertebral fracture of unknown 
timing) was 6.6% in the total group (Figure 1) 8.
In patients with of one or more radiographic vertebral fractures at baseline, in 
whom the timing of fractures was unknown, the risk of sustaining a radiographic 
vertebral fracture increased by 5-fold during the initial year of the study com-
pared with the incidence in subjects without prevalent radiographic vertebral 
fractures at baseline (relative risk [RR], 5.1; 95% confidence interval [CI], 3.1-8.4; p 
< 0.001). The 1-year AR for a first radiographic vertebral fracture was 1.9%, 4.6% 
in the presence of one vertebral fracture of unknown radiographic vertebral frac-
341Timing of subseq fractures and mortality after an initial fracture
ture and 9.9% and 12.5% in the presence of more than one or two radiographic 
vertebral fractures of unknown timing at baseline, respectively 8.
Among the 381 participants who developed an incident radiographic vertebral 
fracture during the study follow up, the incidence of a new radiographic verte-
bral fracture in the subsequent year was 19.2% (95% CI, 13.6-24.8) 8. In summary, 
this study indicated that the 1-year AR for subsequent radiographic vertebral 
fractures is 1.9% for a first radiographic vertebral fracture, 4.6% in the presence of 
a radiographic vertebral fracture of unknown timing and 19.2% within one year 
after a radiographic vertebral fracture had occurred. This study clearly showed 
that the risk of repeat radiographic vertebral fractures is highest during the first 
year after a radiographic vertebral fracture. 
Fractures after clinical vertebral fractures 
A study focused on the magnitude and time course of the increase in risk of 
further fractures during a mean follow up of 2.4 years (maximum 8 years) in 
patients who were hospitalized for vertebral fracture (n=28,869) 7. It has been 
shown that there was a marked increase in subsequent incidence of hip and all 
fractures within the first year following hospitalization for vertebral fracture in 
both men and women. Thereafter, fracture incidence declined toward, but did 
not attain baseline risk. The increase in fracture risk was more marked following 
low-energy vertebral fracture than following high-energy trauma. The RR for an 
incident fracture (compared with the general population) was at any age higher 
at 6 months (3.9 to 48.7, according to age) than at 4 years (1.4 to 15.2, according 
Figure 1. One-year absolute risk (AR) for first and repeat radiographic vertebral fractures 
(VF)8 
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Figure 1. One-year absolute risk (AR) for first and repeat radiographic vertebral fractures 
(VF)8 
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to age), was higher in men (5.6 to 48.7, according to age) than in women (3.9 to 
32.0, according to age), and was higher in younger than in older patients (Figure 
2). The AR, expressed as the incidence of all subsequent fractures, was higher at 6 
months (7.8% to 21.5%, according to age) than at 4 years (1.9% to 10.2%, according 
to age) and higher in women (8.0% to 21.5%, according to age) than in men (7.8% 
to 16.0%, according to age) 7. The timing of the percentage of fracture according 
to time of follow up was not mentioned.
CLuSTerIng In TIMe oF FraCTureS aFTer a HIP FraCTure 
A total of 799 patients were followed during a mean follow up of 22 years af-
ter their initial hip fracture. After the initial hip fracture, 27% of all subsequent 
fractures (mean number of subsequent fractures per patient: 2.3, range 1 to 11 
fractures/patient) occurred within 2 years and 73% within 5 years 12. The AR over 
22 years was 45% in the total group and 86% in survivors. This indicates that the 
2-year AR was ~12% in the total group and ~23% in survivors and that the 5-year 
AR was 33% and 63%, respectively 12. 
A study in elderly living in a nursing home (n=184) showed the same trend. The 
AR of the subsequent fractures was 12% within one year and 21% within 5 years 
Figure 1. One-year absolute risk (AR) for first and repeat radiographic vertebral fractures 
(VF)8 
 
 
Figure 2. Risk ratio and absolute risk of subsequent fracture 6 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Percentage of subsequent fractures during a 5-year follow-up period 6 
0
10
20
30
40
50
60
50 55 60 65 70 75 80 85
Men at 6 mo
Men at 4 yr
0
10
20
30
40
50
60
50 55 60 65 70 75 80 85
Women at 6 mo
Women at 4 yr
0
5
10
15
20
25
50 55 60 65 70 75 80 85
Men at 6 mo
Men at 4 yr
0
5
10
15
20
25
50 55 60 65 70 75 80 85
Women at 6 mo
Women at 4 yr
Figure 2. Risk ratio and absolute risk of subsequent fracture 6
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indicating that more than half of subsequent fractures during 5 years follow up 
occurred within one year after a hip fracture 13. 
In a study that included >170,000 men and women with an initial hip fracture 
almost 28,000 patients sustained a subsequent hip fracture during 25 years 
follow up (mean follow up: 3.8 years). After a first hip fracture, the cumulative 
incidence of subsequent hip fracture was 9% within 1 year and 20% within 5 
years, compared to 2% and 12%, respectively, in subjects without a hip fracture. 
Thus, nearly half of all subsequent hip fractures during 5 years follow up occurred 
within 1 year. The RR for a second hip fracture was 11.8 at 1 month, decreasing 
exponentially to 3.0 at 6 months and 2.2 at 1 year, and did not normalise until after 
15 years 14. Risk factors for a second hip fracture were female sex, age, alcoholism, 
any prior fracture, living alone and having a higher income 14. 
Similar results were reported in other studies 15, 16. In addition, almost all frac-
tures after the initial hip fracture were caused by low-energy traumatic accidents 
(e.g. fall from standing height or less, fall from a chair or fall out of bed) 12-16. 
CLuSTerIng In TIMe aFTer CLInICaL FraCTureS 
One study focused on the risk of hip, forearm, clinical vertebral or shoulder 
fractures in women and men between 60 and 80 years from the time they had 
a hip, clinical vertebral or shoulder fracture in both outpatients and hospitalised 
patients 6. Of all subsequent hip, clinical vertebral, forearm or shoulder fractures 
during a follow up of 5 years, 34% occurred within the first year after the initial 
fracture (range 31-45%) and progressively decreased to 9% during the 5th year 
(Figure 3) 6. 
We published a population based study focusing on all clinical fractures 
(including high-energy or low-energy trauma fractures) in postmenopausal 
women 5. During a follow up of 20 years (mean: 9 years), 23% of all subsequent 
fractures were sustained within one year after the initial fracture and 54% within 
5 years. After 15 years the subsequent fracture risk was no longer higher than the 
initial fracture risk 5. 
In the DUBBO study in Australia, in community-dwelling men and women older 
than 60 years, the absolute risk of subsequent low-energy trauma fracture was 
similar for men and women 4. About 41% of the subsequent fractures in women 
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and 52% in men occurred within two years after the initial fracture during a follow 
up of 16 years. This clustering of fractures occurred regardless of the initial fracture 
location. However, with the expected increase in initial fracture risk with age, 
the excess risk decreased over time from initial fracture (p=0.003 and P=.001 for 
women and men, respectively). After 10 years of follow-up, the subsequent abso-
lute fracture risk was no longer elevated compared with the risk of a first fracture. 
In a retrospective study, the time relation between fractures was studied 
between the time of prior fracture (n=>8,000) and the time a BMD measurement 
was performed, and the risk of subsequent fracture (n=>1700) during a follow up 
for a maximum of 10 years after the index BMD measurement 17. The RR after major 
fractures was 1.9 (95% CI: 1.6-2.3) after the BMD measurement in patients who had 
a fracture history <1 year before the BMD measurement, decreasing towards 1.6 
(95% CI: 1.3-2.1) if the previous fracture had occurred >10 years ago (p<0.001 for 
trend). After minor fractures, the RR was 1.49 (95% CI: 1.1-1.9) and 1.1 (95%CI: 0.8-
1.5), respectively 17. However, this study did not report the exact timing between 
fractures as the timing from BMD measurement and subsequent fracture was not 
reported. In view of the large database in that study, more detailed analysis of the 
time relation between fractures would be of interest.
The aetiology of clustering of fractures needs further investigation in terms 
of bone-related (e.g. cortical and trabecular bone loss due to immobility), fall-
related risk factors (e.g. immobility, postural instability, muscle strength, plaster-
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Figure 3. Percentage of subsequent fractures during a 5-year follow-up period 6
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ing, use of walking device) and post-fracture care for morbidity (e.g. locomotor 
revalidation after lower limb fractures).  
ConCLuSIon
The clustering of fractures in time indicates the need for immediate attention in 
both men and women who sustain a first fracture to prevent the occurrence of a 
subsequent fracture. The high increase of subsequent fractures immediately after 
a first fracture creates a window of opportunity to prevent subsequent fractures. 
However, no studies are available on fracture prevention immediately after a frac-
ture. Such studies will be needed in view of the immediate burden of subsequent 
fractures in patients with a first fracture, who can easily be identified clinically.
In addition, when treatment with osteoporosis medication is considered, such 
treatment should be chosen on the basis of proven short-term efficacy in the 
reduction of vertebral and non-vertebral fractures. How far additional fall pre-
vention strategies would further decrease subsequent fracture risk is unknown 
and a field for further clinical research. 
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** Center, J.R., D. Bliuc, T.V. Nguyen, and J.A. Eisman, Risk of subsequent fracture 
after low-trauma fracture in men and women. JAMA 2007;297(4): 387-94.
This study examined the subsequent risk of all fracture types, except fingers 
and toes, after an initial low-energy trauma fracture in men and women aged 60 
years and over taking into account the time relation between fractures. The risk 
of subsequent fracture was highest immediately after the initial fracture, but was 
no longer higher than the risk for individuals without a fracture 10-years after the 
initial fracture (41% of the subsequent fractures occurred within two years). 
* Berry, S.D., E.J. Samelson, L. Ngo, et al., Subsequent fracture in nursing home 
residents with a hip fracture: a competing risks approach. J Am Geriatr Soc 
2008;56(10): 1887-92.
In long-term care residents with a surgically repaired hip fracture, 21% sus-
tained a subsequent fracture: 6% of residents experienced a subsequent fracture 
within six months, 12% within one year, and 21% within five years.
** Geel van, T.A.C.M., S. Helden van, P.P. Geusens, et al., Clinical subsequent 
fractures cluster in time after first fractures. Ann Rheum Dis 2009;68(1): 99-102.
The results of this study, extend the observations of Center et al. to all clinical 
vertebral and non-vertebral fractures, in women from menopause onwards, and 
for both low- and high-energy trauma fractures. The initial fracture type was 
no predictor for subsequent fractures. Tthe subsequent fracture risk remained 
higher, compared with initial fracture risk,  for 15 years after the initial fracture 
(23% of the subsequent fractures occurred within one year). 
** Ryg, J., L. Rejnmark, S. Overgaard, et al., Hip Fracture Patients at Risk of Sec-
ond Hip Fracture-A Nationwide Population-Based Cohort Study of 169,145 Cases 
During 1977-2001. J Bone Miner Res 2009.
Approximately 170.000 patients with an initial hip fracture were included in 
this 25 year follow-up study. The cumulative incidence showed that 9% of the 
subsequent hip fractures were suffered within one year and 20% within five 
years. The risk for a subsequent fracture remained significantly higher than the 
risk for individuals without a fracture for 15 years after the initial fracture. 
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aBSTraCT
Introduction
We analysed whether a combination of bone- and fall-related risk factors (RFs) in 
addition to a recent non-vertebral fracture (NVF) contributed to subsequent NVF 
risk and mortality during 2-years in patients who were offered fall and fracture 
prevention according to Dutch fracture- and fall-prevention guidelines.
Methods
834 consecutive patients aged ≥50 years with a recent NVF who were included. 
We compared subgroups of patients according to the presence of bone RFs and/
or fall RFs (group 1: only bone RFs; group 2: combination of bone and fall RFs; 
group 3: only fall RFs; group 4: no additional RFs). Univariable and multivariable 
Cox regression analyses were performed adjusted for age, sex and baseline frac-
ture location (major or minor). 
results 
57(6.8%) had a subsequent NVF and 29 (3.5%) died within 2-years. Univariable 
Cox regression analysis showed that patients with the combination of bone 
and fall RFs had a 99% higher risk in subsequent fracture risk compared to all 
others (Hazard Ratio (HR) 1.99; 95% Confidence Interval (CI) 1.18-3.36) Multivari-
able analyses this was borderline not significant (HR 1.70; 95% CI: 0.99-2.93). No 
significant differences in mortality were found between the groups.
Conclusion
Evaluation of fall RFs contributes to identifying patients with bone RFs at high-
est immediate risk of subsequent NVF in spite of guideline-based treatment. It 
should be further studied whether earlier and immediate prevention following a 
NVF can decrease fracture risk in patients with a combination of bone and fall RFs.
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InTroduCTIon
For persons above fifty years of age, a history of fracture doubles the risk of a 
subsequent fracture1. This risk is highest immediately after the fracture, with 
a 5- to 25-fold increase of subsequent fracture risk within the first months and 
years 1-6. In patients with a recent fracture, other bone-related clinical risk factors, 
low bone mineral density (BMD) and fall-related risk factors are often present 7. 
These risk factors are independently related to fracture risk and are used in algo-
rithms to calculate fracture risk, like FRAX® 8 and Garvan Fracture Risk calculator9. 
In addition, fall-related risk factors predict not only the risk of subsequent falls, 
but also of fractures. Therefore, these risk factors are sometimes integrated in 
fracture prediction algorithms9 . 
Fracture risk reduction has only been shown with specific anti-osteoporosis 
medication such as bisphosphonates, denosumab, raloxifene and recombinant 
PTH 4, 10-17. Fall prevention strategies decrease the risk of falls, however in these 
studies prevention of fractures was not demonstrated 18.
In the field of post fracture care, a Fracture Liaison Service is one of the ini-
tiatives to integrate evaluation of bone- and fall-related risk factors in patients 
attending the hospital with a recent clinical fracture 19. 
The aim of the Fracture Liaison Service is to evaluate bone- and fall-related 
risk factors, to initiate fall prevention programs, adequate calcium and vitamin D 
supplementation and specific anti-osteoporosis medication when needed in or-
der to reduce subsequent falls, fractures and mortality 4, 6, 11, 19-21.
In this study, patients with a recent clinical fracture were assessed at the FLS 
at Maastricht University Medical Center for bone- and fall related risk factors and 
we hypothesised that over a 2-year follow-up period the subsequent fracture 
risk and mortality would be highest in patients with a combination of bone- and 
fall- related risk factors, even though these patients received anti-osteoporosis 
treatment and/or fall prevention. 
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MeTHodS
Study design
The Fracture Liaison Service is a collaboration between the department of 
surgery, orthopaedics and internal medicine (rheumatology and endocrinology) 
and is based on the consensus guideline osteoporosis of the Dutch Institute for 
Health Care Improvement (CBO) 20.The Fracture Liaison Service is coordinated by 
a specialised and dedicated fracture nurse. 
Between September 2004 and September 2006 all consecutive patients older 
than 50 years with a recent non-vertebral fracture, who entered the level one 
trauma centre in the south of the Netherlands were invited to participate. Pa-
tients with pathological or vertebral fractures or living outside the postal area 
were excluded. All patients were prospectively followed for two years. The hos-
pital database was searched for radiographically confirmed first and subsequent 
NVF, fracture location and date of occurrence. All NVFs (baseline and subsequent) 
were categorised according to International Classification of Disease (ICD)-9 and 
then pooled into 2 groups: major (hip, pelvis, proximal humerus, proximal tibia, 
multiple ribs or distal femur fracture), and minor (all other) fractures3. All groups 
were mutually exclusive. First and subsequent fractures were classified according 
to the main fracture. The national obituary database was searched to investigate 
whether patients were deceased. 
The study was approved by the medical ethical committee of the hospital (MEC 
03-194).
Measurements
All patients, who were able and agreed to evaluate their fracture risk assessment, 
were invited to attend the Fracture Liaison Service. Medical history, current and 
past medication use, living situation, conditions concerning the occurrence of 
the fracture, dietary calcium and vitamin D intake were assessed. Additionally, 
bone- and fall- related risk factors were systematically assessed, and bone min-
eral density was measured by dual energy X-ray absorptiometry (DXA, Hologic 
QDR 4500) at the lumbar spine and femoral neck. Based on criteria of the World 
Health Organisation osteoporosis was classified as T-score of ≤ -2.5, osteopenia as 
T-score between -1.0 and -2.5, and normal BMD as T-score of >-1.0. 
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According to the national osteoporosis guideline the following bone- and fall-
related risk factors were evaluated: a history of clinical fracture after the age of 50 
years, family history of hip fracture, low body weight (<60 kg), glucocorticoid use 
and immobility (<4 hours per day) 20. Vertebral fractures were excluded from this 
study, since the exact date of occurrence is often unclear. Patients were catego-
rised as having a bone-related risk factor if they had osteoporosis or at least one 
of the above mentioned risk factors. 
According to the national guideline on fall prevention the following fall-related 
risk factors were evaluated: a previous falls in the last 12 months (the fall leading 
to the current fracture was excluded), the presence of Parkinson’s disease, current 
use of psycho-active medication, urinary incontinence (defined as involuntary 
loss of urine) and articular complaints18. Additionally, the Groningen Activity 
Restriction Scale (GARS) was used to estimate the disability in activities of daily 
living (ADL)21. Patients were categorised as having a fall-related risk factor if at 
least one of the risk factors mentioned above was present or the GARS showed 
low ADL. 
According to the Dutch guidelines on osteoporosis and fall prevention pa-
tients started with Calcium and Vitamin D or a bisphosphonate in the presence 
of osteoporosis. 
For the analyses, patients were categorised into subgroups according to 
the presence, combination or absence of bone- and fall-related risk factors: (1) 
patients with only bone-related risk factors, (2) patients with combination of 
bone- and fall-related risk factors, (3) patients with only fall-related risk factors, 
and (4) patients without bone- or fall-related risk factors. The rationale behind 
these groups is that there is a known treatable risk factor in group 1 and 2, but not 
in group 3 because in fracture prevention only bone targeted therapy has shown 
to reduce fracture risk and not fall targeted therapies. 
Statistical analysis
Differences between the groups were analysed using the chi-square or Fisher’s 
exact test for categorical variables. ANOVA and independent samples t-test for 
numerical variables. Kaplan-Meier and multivariable Cox regression analyses 
were performed using subsequent fracture and mortality as dependent variables 
(events), adjusted for age, sex and baseline fracture location (major/minor). For 
subsequent fracture as dependent variable, follow-up time started at time of 
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current fracture (time = 0) and was defined as time between current fracture 
and subsequent fracture (= event), death or end of 2-year follow-up period (= 
censored).  For mortality, follow-up time was calculated as time between cur-
rent fracture and death (= event) or end of 2-year follow-up period (= censored). 
Schoenfeld residuals were used to check the proportional hazards assumption 
and, if violated, time-dependent Cox regression was used. Linearity was checked 
for continuous variables and, if violated, centered quadratic terms were included. 
A two-sided p-value ≤ 0.05 was considered statistically significant. All analyses 
were performed using SPSS for Mac (version 18.0.0; SPSS Inc., Illinois, USA).
reSuLTS
In total 834 patients with a NVF were included. Fifty-seven (6.8%) patients sus-
tained a subsequent NVF and 29 (3.5%) died within two years.
Table 1 shows the patient characteristics for the total studied population, and 
for patients with (n=57) and without a subsequent non-vertebral fracture within 
2 years (n=777). In total, 51.2% of patients had least one bone- and 60.4% had 
at least one fall-related risk factor. One in four patients had a previous clinical 
fracture at 50+ years, almost one in five had a low body weight (<60kg) or a family 
history with a previous hip fracture. The most common Fall-related risk factors 
were articular complaints (31.3%), >1 fall in the preceding year (26.0%) and ex-
posure to psychopharmaca (22.2%). Compared to patients without a subsequent 
fracture, patients with a subsequent fracture were significantly older (70.3 vs. 67.1 
years), more patients had impaired mobility (10.5% vs. 3.9%) and a previous frac-
ture after the age of 50 (38.6% vs. 25.2%), but less often had urinary incontinence 
(24.6% vs. 13.6%). Additionally, patients with a subsequent fracture had more 
often a combination of at least one bone-and one fall-related risk factor (group 
2, 56.1% vs. 38.9%, p<0.01) compared to patients without a subsequent fracture.
Subsequent fracture risk
Comparison of subgroups
Table 2 shows the results all patients according to the pre-specified groups. Pa-
tients with the combination of bone- and fall related risk factors (group 2, n = 334) 
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were significantly older (70.0 years) compared with group 1 (n = 183, 65.6 years), 
group 3 (n = 170, 67.6 years) and group 4 (n = 147, 63.0 years), and were more often 
females (83.2%; 69.4% for group 1; 70.6% for group 3, and 6.5% for group 4). They 
had also sustained more often a major fracture (42.8%) at baseline compared to 
the other groups (group 1: 33.3%; group 3:27.6%; group 4: 23.8%, respectively). 
In absolute terms, no significant difference was found in absolute subsequent 
fracture risk between the groups (p=0.069) (Figure 1, 2 and Table 2).
Total
(n=834)
Subsequent 
fracture 
(n=57; 6.8%)
no subsequent 
fracture 
(n=777; 93.2%)
P-value
age (Sd) 67.3 (10.4) 70.3 (11.1) 67.1 (10.3) 0.023
Sex n (%) 0.022
Women 608 (72.9) 49 (86.0) 559 (71.9)
Men 226 (27.1) 8 (14.0) 218 (28.1)
Fracture location  n (%) 0.874
Major 286 (34.3) 19 (33.3) 267 (32.0)
Minor 548 (65.7) 38 (67.7) 510 (68.0)
Bone rFs (%)
Fracture 50+ yrs 218 (26.1) 22 (38.6) 196 (25.2) 0.027
<60 kg 149 (17.9) 11 (19.3) 138 (17.8) 0.770
Positive family history 144 (17.3) 12 (21.1) 132 (17.0) 0.433
Immobility 36 (4.3) 6 (10.5) 30 (3.9) 0.017
On glucocorticoids 7 (0.8) 0 (0) 7 (0.9) 1.000
At least 1 bone RF 427 (51.2) 36 (63.2) 391 (50.3) 0.061
Fall rFs (%)
>1 fall last year 217 (26.0) 21 (36.8) 196 (25.2) 0.054
On psychopharmaca 185 (22.2) 18 (31.6) 167 (21.5) 0.077
Low ADL (before fracture) 61 (7.3) 8 (14.0) 53 (6.8) 0.043
Articular complaints 261 (31.3) 17 (29.8) 244 (31.4) 0.804
Urinary incontinence 120 (14.4) 14 (24.6) 106 (13.6) 0.023
Parkinson’s disease 5 (0.6) 0 (0) 5 (0.6) 1.000
At least 1 of the fall RF 504 (60.4) 39 (68.4) 465 (59.8) 0.201
Table 1. Comparison of characteristics of patients with and without a subsequent fracture
P-value refers to differences between patients with and without subsequent fracture
Chi-square and Fisher’s exact tests were used for categorical variables and independent-samples t-tests 
for numerical variables.
Abbreviations: ADL: activity of daily living
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Total
n=834
group 1
BrF
n=183
group 2
Combination 
of rFs
n=334
group 3
FrF
n=170
group 4
no rFs
n=147
P value
age (Sd) 67.3 (10.4) 65.6 (9.5) 70.0 (10.4) 67.6 (10.8) 63.0 (8.7)
Sex  n (%) <0.001
Women 608 (72.9) 127 (69.4) 278 (83.2) 120 (70.6) 83 (56.5)
Men 226 (27.1) 56 (30.6) 56 (16.8) 50 (29.4) 64 (43.5)
Fracture location  n (%) <0.001
Major 286 (34.3) 61 (33.3) 143 (42.8) 47 (27.6) 35 (23.8)
Minor 548 (65.7) 122 (66.7) 191 (57.2) 123 (72.4) 112 (76.2)
Subsequent fracture n (%) Total 57 (6.8) 9 (4.9) 32 (9.6) 7 (4.1) 9 (6.1) 0.069
1st year 34 (59.6) 3 (33.3) 22 (68.8) 3 (42.9) 6 (66.7)
2nd year 23 (40.4) 6 (67.7) 10 (31.2) 4 (57.1) 3 (33.3)
Mortality n (%) 29 (3.5) 6 (3.3) 13 (3.9) 7 (4.1) 3 (2.0) 0.728
Table 2. Comparison of all patients according to their pre-specified groups
Chi-square and Fisher’s exact tests were used for categorical variables and ANOVA F-tests for numerical 
variables.
 
 
Figure 1 All patients according to their pre-specified groups 
A Venn diagram 
B Histogram  
 
 
 
 
 
 
 
 
 
0
1
2
3
4
5
6
7
8
9
10
BRF Combination FRF no RF
total
1st
2nd
Figure 1. All patients according to their pre-specified groups
A Venn diagram
B Histogram 
459The role of the combination of BRF and FRF on short-term subseq fracture risk and mortality
Patients with a combination of bone- and fall-related risk factors versus all other 
patients
Univariable Cox analysis showed that patients with a combination of risk factors 
had a significantly higher subsequent fracture risk than all other patients (HR: 
1.99, 95%CI: 1.18-3.36 p=0.010) (Figure 3). However, after adjusting for age, sex and 
baseline fracture location (multivariable model) the subsequent fracture risk was 
not significantly higher (borderline) in the multivariable model (HR 1.70, 95%CI: 
0.99-2.93; p=0.055).
 
Figure 2 Multivariable Cox regression analyses stratified by groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Multivariable Cox regression.
Analyses stratified by groups
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Patients with a combination of risk factors compared to group 1 (only bone-
related risk factors) 
Patients with the combination of risk factors did not have a significantly higher 
subsequent fracture risk than patients with only bone-related risk factors in 
univariable (HR 2.04; 95%CI: 0.97-4.27) or multivariable analyses (HR 1.67; 95%CI: 
0.79-3.54). However, the plot of the Kaplan-Meier curves indicated that the subse-
quent fractures occurred immediately after the current fracture in the combina-
tion group, while this was not the case for the patients with only bone-related 
risk factors (Figure 4). This time-dependency was confirmed by the Schoenfeld 
residuals and the time-dependent Cox regression model (p = 0.024). However, 
the number of events is too low to draw reliable conclusions.
 
Figure 3 Kaplan Maier curve 
Cumulative subsequent fracture incidence in patients with the combination of risk factors 
(group 2) compared with all other patients (group 1, 3 and 4)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3. Kaplan Maier curve
Cumulative subsequent fracture incidence in p ts with the combination of risk factors (group 2) 
compared with all other patients (group 1, 3 and 4) 
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Patients with a combination of risk factors compared to group 3 (only fall-related 
risk factors) 
In univariable analysis, patients with the combination of risk factors had a higher 
risk of subsequent fractures compared with patients with only fall-related risk 
factors (HR 2.41, 95%CI: 1.06-6.46). In the multivariable model, the subsequent 
fracture risk was no longer significantly higher (HR 2.05; 95%CI: 0.90-4.69).
Patients with a combination of risk factors compared to group 4 (no bone- or fall-
related risk factors) 
No significant differences were found between the groups on subsequent frac-
ture risk within 2-years after univariable (HR 1.61; 95% CI: 0.77-3.38) and multivari-
able cox regression analyses (HR 1.16; 95% CI: 0.53-2.55). 
Mortality
Within two years after baseline fracture 26 patients were deceased (3.5%). In 
univariable Cox regression analysis, no significant difference was found between 
patients with a combination of bone- and fall-related risk factors (group 2) and 
all other groups, as well as between group 2 and all groups separately. Due to 
 
Figure 4 Kaplan Maier curve 
Fracture free probability of the combination versus BRF, adjusted for age, sex and baseline 
fracture location. 
 
Figure 4. Kaplan Maier curve
Fracture free probability f the combination versus BRF, adjusted for age, sex and baseline fracture 
location.
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the small number of deceased patients in the present study, no multivariable 
regression analyses were performed. However, this only reflects the very selected 
nature of our cohort, as the majority of patients were still alive within 2 years after 
their baseline fracture.
dISCuSSIon
Subsequent fracture incidence 
The subsequent non-vertebral fracture risk in patients with a combination of 
bone- and fall-related risk factors was nearly double the risk of all other patients 
in univariable analysis (HR 1.99 (95% CI: 1.18-3.36). In multivariable analysis this 
tendency was also shown, but it did not reach significance (HR 1.70; 95%CI: 0.99-
2.93). This is partly explained by the low event rate. There was a time-dependency 
when comparing patients with a combination of risk factors to patients with only 
bone-related risk factors (data not shown). This indicates that, in spite of Fracture 
Liaison Service assessment, patients with a combination of risk factors still had a 
high fracture risk at short term. Many studies have shown that the risk of subse-
quent fracture is highest immediately after a fracture, such as repeat vertebral, 
hip and non-vertebral fractures 3, 6, 22, 23. However, the event rate was lower in 
our research compared to other published articles. In a study among patients 
aged 60 years and over a relative risk of subsequent fracture incidence of 1.95 
in women and 3.45 in men was found3. A subsequent fracture risk of 10.8% was 
found within 2-years after a fracture, and of 17.6% in patients of 50+ years who 
sustained a NVF after a NVF4, 5. The two retrospective studies were performed ac-
cording to intention-to-treat, and therefore, a difference in subsequent fracture 
rate and mortality could be found. Mortality is known to be increased after a 
fracture, especially after a hip fracture24. A recent study showed an increased risk 
of mortality especially within 5-years after the fracture11. In the described studies, 
3, 4, 5, 24, 11 not all patients were treated at a Fracture Liaison Service. This might 
explain the lower subsequent fracture (6.8%) and mortality rate (3.5%) in our 
study compared with the studies mentioned above (due to a possible treatment 
effect). In addition, the minimum age of inclusion was different, and only patients 
who did attend the Fracture Liaison Service were included. 
463The role of the combination of BRF and FRF on short-term subseq fracture risk and mortality
There was a time-dependency with regard to subsequent fracture risk in 
patients who had both bone- and fall-related risk factors with the highest risk im-
mediately after the initial fracture. This might be caused by (new) falls and, since 
the bone is already vulnerable due to the initial fracture, subsequent fractures 
mostly occur in this subgroup short-term after the initial fracture. 
Therefore, patients with a combination of bone- and fall-related risk factors, 
are definitely candidates for immediate fracture prevention combined with fall 
prevention. 
However, of the patients without additional risk factors 6.1% had a subsequent 
fracture within 2-years of follow-up. Presumably other risk factors that are not 
captured by the bone- and fall- related risk assessment in this study play a role 
in the occurrence of subsequent fractures. On the other hand, all patients in this 
study had a recent fracture, which is by itself a major independent risk factor for 
subsequent fractures. As a consequence, this might imply that all patients with 
an initial NVF, whether or not additional risk factors are present, deserve subse-
quent fracture prevention regardless of other risk factors. This is also proposed 
in the UK guideline 25.
Mortality 
No difference was found between the groups for mortality rate. This could be the 
result of the low mortality rate (n=29) in this study in combination with the rela-
tively short follow-up period (two years). A study with a longer follow-up period 
in a larger population is necessary to further study these findings. Treatment of 
osteoporosis with bisphosphonates might reduce mortality rate. The mechanism 
by which this operates remains unclear, but its effect on subsequent fracture risk 
or on extra skeletal sites might be two possibilities 11, 26, 27. Integrating guidelines 
on prevention of falls, fractures and identification and treatment of osteoporosis 
is recommended to optimise post fracture care. However, integrating these 
services is difficult and still has to be achieved in many centers 28. 
Strengths and limitations 
The strength of this study is that all consecutive patients with a recent non-
vertebral fracture who attended the Fracture Liaison Service were included in the 
analyses. Furthermore, a dedicated fracture nurse performed the assessments of 
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well-defined clinical, bone- and fall-related risk factors according to the national 
Osteoporosis and Fall Prevention Guidelines20, 21.  
A limitation of this study is that there are no data on prescription and adher-
ence of the proposed osteoporosis treatment and fall prevention. Persistence 
might be low, as has been shown in a recent publication for oral anti-osteoporosis 
medications in the Netherlands 29. Due to the low mortality rate, no in depth 
analysis of the role of risk factors could be performed. However, this could also 
be a strength, since one of the effects of the Fracture Liaison Service might be 
mortality risk reduction.
Conclusions 
In patients with a recent non-vertebral fracture who had a combination of bone- 
and fall-related risk factors, the risk of subsequent fractures was almost doubled 
compared with the other patients. These patients also had a higher subsequent 
fracture risk immediately after the initial fracture compared with patients in 
whom only bone-related risk factors were present. 
Therefore, not only bone- but also fall-related risk factors should be assessed in 
order to identify patients at highest immediate risk of subsequent NVF. 
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aBSTraCT
Introduction
The aim of the study was to evaluate the implementation of case finding ac-
cording to guidelines for osteoporosis in fracture patients presenting at Fracture 
Liaison Services (FLSs) in The Netherlands.
Methods
Five FLSs were contacted to participate in this prospective study. Patients older 
than 50 years with a recent clinical fracture who were able and were willing to 
participate in fracture risk evaluation were included. Performance was evaluated 
by criteria for patient recruitment, patient characteristics, nurse time, evaluated 
clinical risk factors (CRFs), bone mineral density (BMD) and laboratory testing and 
results of CRFs and BMD are presented. Differences between FLSs were analysed 
for performance (by chi square and Student t-test) and for prevalence of CRFs (by 
relative risks (RR)). 
results
All FLSs had a dedicated nurse, spending 0.9 to 1.7 hours per patient. During 39 
to 58 months follow up, 7199 patients were evaluated (15 to 47 patients/centre/
month, mean age 67 yrs, 77% women). Major differences were found between 
FLSs in performance of patient recruitment, evaluation of CRFs, BMD and labora-
tory testing, varying between 0 and 100%. The prevalence of CRFs and osteopo-
rosis varied significantly between FLSs (RR between 1.7 and 37.0, depending on 
the risk factor).
Conclusion 
All five participating FLSs with a dedicated fracture nurse differed in performance 
of patient selection, CRFs and in the prevalence of CRFs, indicating the need for 
more concrete and standardised guidelines to organise evaluation of patients at 
the time of fracture in daily practice. 
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InTroduCTIon
Osteoporotic fractures represent a major growing public health issue. The num-
ber of fractures in the elderly is expected to increase mainly due to the world’s 
ageing population 1. Bone mineral density (BMD) measured by Dual Energy 
X-ray Absorptiometry (DXA) scan alone is not sufficient to provide an accurate 
prediction of fracture risk. Other clinical, non-BMD risk factors are known to be 
important for estimating an adequate probability of fracture 2, 3. A previous frac-
ture doubles the risk for future fractures and vertebral fractures quadruple this 
risk 4, 5, and even more so at short term 6-10. Recently, the World Health Organiza-
tion (WHO) developed a Fracture Risk Assessment (FRAX) tool to evaluate the 10-
year fracture risk of patients 11. The FRAX tool integrated clinical risk factors (CRFs) 
and BMD to predict the 10-year risk of a major osteoporotic and hip fracture, but 
does not include evaluation of fall risks.
Current Guidelines on Osteoporosis in the Netherlands (developed in 2002) 
recommend that all female patients over 50 years of age with a minimal trauma 
fracture should be investigated by DXA and treated, when having, for osteopo-
rosis 12. Moreover, women aged sixty years and over, with all three known risk 
factors for fractures: a family history of fractures, low body weight (<67 kg) or 
immobility, should be investigated by DXA scan for osteoporosis. Women over 
the age of 70 merely require two of these risk factors 12. 
A Fracture Liaison Service (FLS) is one of the initiatives in the field of post fracture 
care to integrate osteoporosis assessment 13-16. An evaluation of FLSs allowed to 
identify similarities and differences in performance of evidence based medicine 
and prevalence of CRFs, and can be helpful to detect strengths and weaknesses 
of guideline advices and their implementation. The results of previous studies 
encouraged the start of several FLSs throughout the Netherlands 13-15, 17, 18. 
The aim of the present study was to identify 1/ similarities and differences in 
performance, and 2/ the prevalence of CRFs in patients presented at FLSs in five 
large hospitals in The Netherlands. 
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MaTerIaL and MeTHodS
Study design 
This prospective, observational study was conducted in five FLSs of hospitals in 
the Netherlands, one university hospital and four general hospitals. These FLSs 
agreed to respond to an extensive questionnaire on organisational aspects, 
performance and results of examinations about patients who were older than 
50 years of age and who were examined shortly after they presented with a 
recent clinical fracture, in order to prevent subsequent fractures. The results were 
reported by the FLSs in a standardised database. 
FLS procedures
Several organisational aspects were examined: number of patients, in- and exclu-
sion criteria, patient recruitment, fracture location, nurse time, performed exami-
nations (CRFs, DXA, laboratory examinations, circumstances of injury) and results 
of CRFs and DXA. All fractures were categorised using ICD-9 classification (skull, 
spine, clavicle, thorax, pelvis, humerus, radius/ulna, hand, hip, femur, patella, 
tibia/fibula, ankle, foot, multiple, other) and classified as major (pelvis, vertebra, 
distal femur, proximal tibia, multiple ribs and proximal humerus), minor (all other 
excluding major fractures, hip and fingers/toes fractures), hip and fingers/toes, 
according to Center et al 6. Fractures were also divided into hip, humerus, distal 
radius/ulna and tibia/fibula fractures. To evaluate all patients in the analysis all 
remaining fractures were analysed as “other fractures”. 
Statistical analysis 
FLS characteristics were analysed with Pearson Chi square for dichotomous 
variables and independent-samples t-test and analysis of variance (ANOVA) for 
continuous variables. Dichotomous variables were presented as percentages 
or mean with standard deviation (SD). Variability of presence of CRFs between 
FLSs were calculated as relative risks (RR), i.e. as the relative difference between 
highest and lowest prevalence. A p-value ≤0.05 was considered as statistically 
significant. All statistical analyses were performed using SPSS software 15.0 for 
Windows (SPSS Inc. Illinois, USA).
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reSuLTS
Implementation of the national osteoporosis guideline at the FLSs
Performance 
During a follow-up between 39 to 58 months, depending on the FLS, 7199 pa-
tients over the age of 50 years were examined at the FLS (range: 847 to 2224 per 
FLS) (Table 1).
All five FLS took initiatives to implement the Guideline on Osteoporosis from 
2002 onwards and had a dedicated nurse, of whom one had specialised training 
as a nurse practitioner (registered nurse with specific advanced nursing educa-
tion) (Table 1). All FLSs reported to consider all patients older than 50 years with 
any fracture for examination. Exclusion criteria differed between FLSs: 4 excluded 
patients with pathological fractures and 4 with high energetic trauma (HET). 
Counselling of the fracture nurse was performed by the trauma-surgeon in two 
FLSs, by an endocrinologist in three or by a rheumatologist or general internist 
in one FLS.
Baseline characteristics (age, sex and CRFs) were screened during the visit at 
the FLSs by questionnaire before their visit to the FLS in 3 centres and by personal 
contact with the nurse in two centres. In 3 centres the patient filled in the ques-
tionnaire and discussed this at the outpatient clinic, in two centres all questions 
were asked by the nurse.
CRFs were examined in all, but recording varied between FLSs. Whether pa-
tients had a history of fracture after the age of 50 years, a family history of hip 
fracture or used glucocorticoids was recorded in >97% of all patients. A history 
of vertebral fracture was asked for in all patients in 4 centres, and in 65% of one 
centre. Low body weight was recorded as a CRF in >94% of patients in 4 centres, 
and in 69% of patients in one centre. A fall during the past year was asked for in 
>99% of patients in 3 centres and in 44% in one centre. In one centre the nurse 
inquired into previous falls in the preceding 6 months (data not shown). DXA 
examinations were performed in 83 up to >99% of patients. Criteria for labora-
tory examinations differed between FLSs: in all patients (n=1), only in men (n=1), 
in men younger than 65 years (n=2), in patients with a T-score <-2.0 (n=1), and in 
women depending on age and T-score (n=2) (Table 1). 
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FLS
% (number of 
patients)
1
30.9% (n=2224)
2
11.8% (n=847)
3
19.6% (n=1409)
4
23.6% n=1699)
5
14.2% (n=1020)
Time period 
studied (months)
47 months 58 months 52 months 54 months 39 months
Patients/month 47 15 27 31 26
Inclusion criteria ≥ 50 years
All fracture types
≥ 50 years
All fracture types
≥ 50 years
All fracture types
≥ 50 years
All fracture types
≥ 50 years
All fracture types
exclusion criteria Dementia
Pathological 
fracture
Dementia
HET
Dementia
Pathological 
fracture
HET
Dementia
Pathological 
fracture
HET
Dementia
Pathological 
fracture
Patient 
recruitment
E-care system ED
Outpatient clinic, 
cast clinic
Outpatient clinic, 
cast clinic
E-care system ED
Through 
radiology reports 
and thereafter 
contacted by 
phone
Through 
radiology reports 
and thereafter 
contacted by 
phone
ED nurse and in 
hospital patients 
via surgeon/
orthopedic 
surgeon
Fracture location 
unknown (%) 
3.3 4.5 0.1 0.4 0.5
nurse 
practitioner
No Yes No No No
nurse Yes No Yes Yes Yes
Time per week 
(hrs)
7x 4 4x 4 2x 8 2x 8; 1x 4 3x 8 
Counselling Trauma- surgeon
Orthopaedic 
surgeon
Internist-
rheumatologist
Internist-
endocrinologist 
(by phone)
Internist-
endocrinologist
Internist-
endocrinologist
Internist
Trauma-surgeon
dXa scan Yes
After 1st visit 
Yes
Before 1st visit
Yes
Before 1st visit
Yes
Before 1st visit
Yes
Before 1st visit
no dXa scan 
results (%)
12.1 17.0 1.0 0.4 9.8
Blood 
examination
Men T-score < -2.0
Osteoporosis
Men <65 years 
and T score ≤-2.5 
Women/Men  <70 
years and T-score 
≤-3.0
Men <65 years 
and T score ≤-2.5 
Women/Men  <70 
years and T-score 
≤-3.0
All patients
Questionnaire Nurse Patient Patient Patient Nurse
CrFs missing (%)
Previous fracture 
≥50 years
0 0 0.3 0 0
Previous 
vertebral 
fracture
0 34.6 0 0 0
Family history of 
hip fracture
0 1.7 0 0 0
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The acute circumstances of trauma were specified in all FLS, but extensively in 
4 (Table 2).
Patient characteristics 
Of the 7199 patients, 76.7% were women. Mean age was 66.7 years (SD 10.0).The 
number of patients included varied between 15 and 47/month/centre. The fracture 
nurse spend between 16 and 24 hours/week at the FLS and therefore the time per 
patient varied between 0.9 and 1.7 hours per patient. Data on fracture locations 
were only available for patients seen at the FLS. No records were available on 
patients who did not consult the FLS. The majority of examined patients sustained 
a distal radius/ulna fracture (n=1828, 26.1%). Hip and tibia/fibula fractures occurred 
in 397 (5.7%) and 900 (12.9%) patients, respectively, and humerus fractures in 854 
(12.2%). Most frequent fractures in women were radius/ulna fractures (n=1582; 
29.5%), humerus fractures (n=702; 13.1%) and fractures of the foot (n=634; 11.8%) 
(Table 3). Men sustained primarily hand fractures (n= 264; 16.1%), radius/ulna frac-
tures (n=246; 15.0%) and foot fractures (n=186; 11.3%) (Table 3).  
Significant differences between FLSs were found for major fractures (13.4-
18.1%), minor fractures (65.5-78.5%), hip fractures (1.0-7.6%) and fractures of 
fingers or toes (0.9-12.6%) (p<0.001 between FLSs) (Table 2).
The acute circumstances of injury were extensively reported by 4 FLSs. Trauma’s 
occurred at home in 28.2 to 58.4% of patients and at work in 0.2 to 2.0%. An injury 
Immobility 0 48.4 0 0 0
Low body weight 
(<60kg)
30.5 2.5 1.6 5.7 5.3
use of 
corticosteroids 
0 2.5 0 0 0
Fall risks missing 
(%)
Fall in preceding 
12 months
0 56.2 0.3 0.1 100 *
Fracture due 
to fall from 
standing height
0 48.4 0 0 0
Table 1. overview of performance and procedures in the 5 FLSs
Abbreviations:
HET: high energetic trauma; ED: Emergency Department; BMD: bone mineral density; DXA: dual energy 
X-ray absorptiometry
* One FLS inquired into fall risk assessment with a different question
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1 2 3 4 5 all rr * P-value**
age (Sd) 67.5(10.7) 69.0(10.5) 65.6(9.3) 65.4(9.2) 67.0(10.2) 66.7(10.0) <0.001
Sex (%) <0.001
Women 74.2 88.2 70.0 79.9 77.0 76.7
Men 25.8 11.8 30.0 20.1 23.0 23.3
Fracture location (%) <0.001
Major 18.1 15.3 13.4 14.6 14.8 15.5
Minor 70.3 78.5 66.3 65.5 75.9 70.1
Hip 5.5 5.3 7.6 7.3 1.0 5.7
Fingers/Toes 6.1 0.9 12.6 12.6 8.4 8.7
Hip 5.5 5.3 7.6 7.3 1.0 5.7
Humerus 13.7 12.3 9.9 11.0 14.3 12.2
Distal radius/ulna 25.8 22.4 26.8 26.9 27.2 26.1
Tibia/fibula 12.7 12.8 13.3 12.7 12.8 12.9
Other 42.3 47.1 42.4 42.1 44.7 43.2
BMd (%) <0.001
Normal BMD 23.7 5.0 26.6 15.5 30.3 21.2
Osteopenia 44.7 54.3 46.2 45.5 47.5 46.6
Osteoporosis 31.6 40.7 27.2 39.0 22.2 32.2
CrF (%)
Previous fracture ≥50 years 25.9 12.6 21.4 16.4 23.9 20.9 2.1 < 0.001
Previous vertebral fracture 6.8 9.6 6.0 5.8 9.3 7.0 1.7 < 0.001
Family history of hip fracture 15.4 7.3 8.9 18.6 26.9 15.6 3.7 < 0.001
Immobility 3.0 0.7 0.4 0.9 10.7 2.9 26.8 < 0.001
Low body weight (<60kg) 19.0 17.0 13.1 13.8 8.6 14.4 2.2 < 0.001
Use of corticosteroids 0.7 7.4 0.2 1.6 5.0 2.2 37.0 < 0.001
Fall risk (%)
Fall in preceding 12 months 20.5 21.8 3.7 14.4 No data ^ 14.1 5.9 < 0.001
Fracture due to fall from 
standing height
80.6 91.1 81.5 81.3 51.0 77.2 1.8 < 0.001
Prevalence etiology of the 
fracture (%)
Accident at home 28.2 58.4 31.5 34.9 42.8 34.7 2.1 < 0.001
Accident at work 1.6 0.2 1.4 2.0 2.6 1.7 10.0 0.021
Fall accident 80.6 91.1 81.5 81.3 51.0 77.2 5.9 < 0.001
Traffic accident 11.0 23.3 14.4 26.9 7.7 16.0 3.5 < 0.001
Sport accident 4.0 3.0 5.7 7.1 4.5 5.1 2.4 < 0.001
Etiology unknown 4.7 8.0 3.8 2.1 1.6 3.6 5.0 < 0.001
Etiology other 6.8 0.5 17.5 6.6 2.8 7.9 35.0 < 0.001
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was reported to be a fall in 51.0 to 91.1%, a traffic accident in 11.0 to 26.9% and 
a sport injury in 3.0 to 7.1%.  Overall, 77.2% of all fractures were caused by a fall 
(Table 2). 
Prevalence 
Significant differences were found in the prevalence of CRFs between FLSs 
(p<0.001 for all CRFs). A history of fracture after the age of 50 years was reported 
by 12.6 to 25.9% of patients, a previous vertebral fracture in 5.8 to 9.6%, a fam-
ily history of hip fracture by 7.3 to 26.9%, immobility by 0.4 to 10.7%, low body 
weight by 8.6 to 19.0%, use of glucocorticoids by 0.2 to 5.0% and a fall during 12 
months before the current fracture by 3.7 to 21.8%. The majority of patients had 
osteopenia (n=3107, 46.6%) and nearly one in three patients had osteoporosis 
(n=2147, 32.3%). More women than men were diagnosed with osteoporosis (35.2% 
vs. 22.9%; p<0.001) or osteopenia (45.9% vs. 48.5%; p<0.001) (Figure 1). Significant 
Table 2.
Prevalence of CRFs, falls and circumstances of trauma in all patient cohort and according to the different 
FLSs
* RR is calculated as a ratio between the highest en the lowest prevalence of CRFs, fall risk and prevalence 
of etiology of the fracture
** P-value is calculated by using chi square, student t-test and ANOVA, and refers to a comparison 
between the 5 FLSs 
^ One FLS inquired into fall risk assessment with a different question
Women Men all P-value
Fracture sites (%) <0.001
Major 15.6 15.6 15.6
Minor 71.6 65.1 70.1
Hip 5.3 7.0 5.7
Fingers/Toes 7.6 12.3 8.7
<0.001
Hip 5.3 7.0 5.7
Humerus 13.1 9.3 12.2
Distal radius/ulna 29.5 15.0 26.1
Tibia/fibula 12.2 15.1 12.9
Other 40.0 53.6 43.2
Table 3.
Frequencies of fracture according to gender 
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differences between FLSs were found in the prevalence of osteoporosis (in 22.2 to 
40.7%), osteopenia (in 44.7 to 54.3%) and normal BMD (in 5.0 to 30.3%) (p<0.001).
Variability, expressed as RR between the CRFs, ranged from RR 1.7 to 37.0, 
depending on the risk factor, lowest variability in previous vertebral fracture (RR 
1.7), highest in use of corticosteroids (RR 37.0)(Table 2).  
dISCuSSIon
In this prospective study in patients older than 50 years presenting with a recent 
clinical fracture at 5 large FLSs in The Netherlands, a dedicated fracture nurse was 
the central responsible coordinator to identify fracture patients, to evaluate risk 
factors for subsequent fractures and to organise secondary fracture prevention 
after counselling by the surgeon, endocrinologist or rheumatologist. Nearly 150 
patients were examined per month resulting in nearly 7,200 evaluated patients 
during 250 months in total. This indicates that specialists in these hospitals made 
a major effort to implement the guidelines of case finding of osteoporosis and 
fall prevention in daily practice.  
The fracture nurse did spend 0.9 to 1.7 hours per patient, indicating that organi-
sation of post-fracture care is labour-intensive. It should be further investigated 
 
 
Figure 1 
Bone mineral density according to sex and fracture location 
Only patients with hip, humerus, distal radius/ulna and tibia/fibula fractures are evaluated in  
this figure.  
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Figure 1.
Bone mineral density according to sex and fracture location
Only patients with hip, humerus, distal radius/ulna and tibia/fibula fractures are evaluated in this figure. 
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which components of this work (such as patient contact, administrative tasks for 
appointments, reporting to the GP) are the most time consuming and how this 
time spending can be optimalised.   
1/ Performance
Most CRFs that were mentioned in the questionnaire to the FLSs were recorded, 
with the exception previous vertebral fracture, immobility, low body weight and a 
fall in the preceding 12 months in one centre. Bone densitometry was performed 
in most patients. Reasons for not performing a DXA were not mentioned, but 
is often the result of patients (or their family) who do not agree or not able to 
perform further examinations 17.
Criteria for laboratory investigations were highly variable between FLSs and 
were performed according to age, gender, and BMD as criteria. This variability can 
be the result of the lack of specific guidelines on the role of laboratory investiga-
tions in fracture patients 12. However, several studies indicate that contributors 
to secondary osteoporosis are often present in patients with osteoporosis, with 
and without a history of recent fracture 19, 20. Clearly, more data are necessary 
about the prevalence of contributors to secondary osteoporosis and bone loss 
in fracture patients with and without osteoporosis to specify which laboratory 
examinations should be performed.
The age and sex of patients and fracture location were significantly different 
between FLSs, but less significant from a clinical point of view (differences of 
4.5 years for age, 5.7% for female sex, 4.7% for major fractures), indicating that 
patient selection was quite similar between FLSs.
Of interest is the finding that most fractures resulted from a fall (77.2%), and a 
minority as a result of a traffic or sport accident, as found by others 20. In spite of 
the exclusion of HET, 11% to 27% of traffic accidents were still interpreted as a low-
energy trauma. There is a need to specify which traumas are considered minor 
or major. On the one hand, the definition of ‘fragility’ or ‘osteoporotic’ fractures 
is heterogeneous in the literature 21. On the other hand, however, high-energy 
trauma fractures are as predictive for subsequent fracture risk as low-trauma 
fractures 22. In addition, 5-year subsequent fracture risk is similar after a finger 
or hip fracture, but 5-year mortality is different, being higher after a hip fracture 
than after a finger fracture 10. Thus, in the context of case finding of subsequent 
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fracture risk in patients with a recent fracture, there is presumably no need for 
distinction between high- and low-energy fractures and fracture locations. 
2/ Prevalence 
There was a high variability in the reporting of several CRFs between FLSs. The 
reason for this is unclear. For example for immobility, the variance between 
centres was very high, and could reflect the absence of a clear definition of this 
CRF in the guideline 12. Clearly, to prevent confusion about definitions in daily 
practice risk factors should be specified as concrete as possible in guidelines. 
Differences between FLSs were also found in T-scores and fall risks of the in-
cluded patients per center. In our study, the range of prevalence of osteoporosis 
was 22.2% to 40.7% between centers and for fall risk (fracture due to fall from 
standing height or less) 51.0% to 91.1%. Presumably, not all centers had the same 
interest of formally evaluating fall risk or did not include such evaluation in their 
protocol, in spite of a guideline on fall prevention in the Netherlands.
Recent literature on fracture prevention focuses more on a combination of 
bone and extraskeletal risks in fracture patients 7. This is also expressed in the 
fracture risk assessment tool (FRAX), which predicts future fractures based on 
several CRFs with and without BMD and in the Garvan Fracture risk calculator, 
which also includes fall risk 11, 23.  
This study has several limitations. 
Firstly, there are no data on all patients who visited the hospitals due to a 
fracture and did not visit the FLS. We only have data on subjects who were able 
and willing to undergo evaluation of their fracture risk, and we can not give a 
percentage of the patients who were willing or not willing to participate. How-
ever, from previous studies is known that 50-85% of the patients at high risk for 
an osteoporotic fracture participate in osteoporosis assessment 13-15, 24. 
Secondly, there is no information about the ethnicity of the participants. 
Thirdly, we do not have data on subsequent fractures of these patients. It 
would be very informative to determine in a cohort of treated fracture patients 
and see whether there is an association between CRFs, BMD and fall risks on 
subsequent fractures and mortality. Possibly, as seen in this study, not all risk 
factors are evenly distributed throughout the fractured patients. 
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Fourthly, almost 6% of all fractures were hip fractures compared to approxi-
mately 18-21% in other studies. It’s possible that our data are not representative 
for hip fracture patients 9, 12. 
In conclusion, when evaluating five FLSs in the Netherlands we found that 
there was a striking difference in prevalence of CRFs and fall risks between elderly 
screened for osteoporosis. Moreover, the study also showed that osteoporosis 
care in the Netherlands is implemented in several hospitals.  
This indicates that prevention strategies to avert subsequent fractures mainly 
have to focus on BMD, CRFs and fall risks and potentially there are differences in 
the presence of risk factors between different fracture types.   
82 Chapter 5
reFerenCeS
 1. Bliuc D, Ong CR, Eisman JA, et al. Barriers to effective management of osteoporosis 
in moderate and minimal trauma fractures: a prospective study. Osteoporos Int 
2005; 16(8):977-82.
 2. Kanis JA. Assessment of fracture risk and its application to screening for postmeno-
pausal osteoporosis: synopsis of a WHO report. WHO Study Group. Osteoporos Int 
1994; 4(6):368-81.
 3. Kanis JA. Diagnosis of osteoporosis and assessment of fracture risk. Lancet 2002; 
359(9321):1929-36.
 4. Kanis JA, Johnell O, De Laet C, et al. A meta-analysis of previous fracture and subse-
quent fracture risk. Bone 2004; 35(2):375-82.
 5. Klotzbuecher CM, Ross PD, Landsman PB, et al. Patients with prior fractures have 
an increased risk of future fractures: a summary of the literature and statistical 
synthesis. J Bone Miner Res 2000; 15(4):721-39.
 6. Center JR, Bliuc D, Nguyen TV, et al. Risk of subsequent fracture after low-trauma 
fracture in men and women. Jama 2007; 297(4):387-94.
 7. Bliuc D, Nguyen ND, Milch VE, et al. Mortality risk associated with low-trauma 
osteoporotic fracture and subsequent fracture in men and women. Jama 2009; 
301(5):513-21.
 8. Ryg J, Rejnmark L, Overgaard S, et al. Hip Fracture Patients at Risk of Second Hip 
Fracture-A Nationwide Population-Based Cohort Study of 169,145 Cases During 
1977-2001. J Bone Miner Res 2009.
 9. van Helden S, Cals J, Kessels F, et al. Risk of new clinical fractures within 2 years 
following a fracture. Osteoporos Int 2006; 17(3):348-54.
 10. Huntjens KM, Kosar S, van Geel TA, et al. Risk of subsequent fracture and mortality 
within 5 years after a non-vertebral fracture. Osteoporos Int.
 11. WHO, Kanis JA. http://www.shef.ac.uk/FRAX/?lang=en. Available at: http://www.
shef.ac.uk/FRAX/index.htm. 
 12. CBO KvdG. Osteoporose, tweede herziene richtlijn. Van Zuiden Communications 
2002.
 13. McLellan AR, Gallacher SJ, Fraser M, et al. The fracture liaison service: success of a 
program for the evaluation and management of patients with osteoporotic fracture. 
Osteoporos Int 2003; 14(12):1028-34.
 14. Blonk MC, Erdtsieck RJ, Wernekinck MG, et al. The fracture and osteoporosis clinic: 
1-year results and 3-month compliance. Bone 2007; 40(6):1643-9.
 15. Hegeman JH, Willemsen G, van Nieuwpoort J, et al. [Effective tracing of osteopo-
rosis at a fracture and osteoporosis clinic in Groningen; an analysis of the first 100 
patients]. Ned Tijdschr Geneeskd 2004; 148(44):2180-5.
583Implementation of OP guidelines: a survey of 5 large FLSs in the NL
 16. Chevalley T, Hoffmeyer P, Bonjour JP, et al. An osteoporosis clinical pathway for the 
medical management of patients with low-trauma fracture. Osteoporos Int 2002; 
13(6):450-5.
 17. van Helden S, van Geel AC, Geusens PP, et al. Bone and fall-related fracture risks 
in women and men with a recent clinical fracture. J Bone Joint Surg Am 2008; 
90(2):241-8.
 18. van Helden S, Cauberg E, Geusens P, et al. The fracture and osteoporosis outpatient 
clinic: an effective strategy for improving implementation of an osteoporosis guide-
line. J Eval Clin Pract 2007; 13(5):801-5.
 19. Tannenbaum C, Clark J, Schwartzman K, et al. Yield of laboratory testing to identify 
secondary contributors to osteoporosis in otherwise healthy women. J Clin Endocri-
nol Metab 2002; 87(10):4431-7.
 20. Dumitrescu B, van Helden S, ten Broeke R, et al. Evaluation of patients with a recent 
clinical fracture and osteoporosis, a multidisciplinary approach. BMC Musculoskelet 
Disord 2008; 9:109.
 21. Sebba A. Comparing non-vertebral fracture risk reduction with osteoporosis thera-
pies: looking beneath the surface. Osteoporos Int 2009; 20(5):675-86.
 22. Mackey DC, Lui LY, Cawthon PM, et al. High-trauma fractures and low bone mineral 
density in older women and men. Jama 2007; 298(20):2381-8.
 23. McLellan AR, Wolowacz SE, Zimovetz EA, et al. Fracture liaison services for the evalu-
ation and management of patients with osteoporotic fracture: a cost-effectiveness 
evaluation based on data collected over 8 years of service provision. Osteoporosis 
international : a journal established as result of cooperation between the European 
Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 
2011; 22(7):2083-98.
 24. Murray AW, McQuillan C, Kennon B, et al. Osteoporosis risk assessment and treat-
ment intervention after hip or shoulder fracture. A comparison of two centres in the 
United Kingdom. Injury 2005; 36(9):1080-4.

Part III
Fracture Liaison Service: risk reduction?

Chapter 6
Impact of guideline implementation by 
a fracture nurse on subsequent fractures 
and mortality in patients presenting 
with non-vertebral fractures
Kirsten MB Huntjens, Tineke ACM van Geel, Piet P Geusens,  
Bjorn Winkens, Paul Willems, Joop PW van den Bergh, Peter RG Brink, 
Svenhjalmar van Helden
Injury (2011) S4:39-43
88 Chapter 6
aBSTraCT 
Introduction
Systematic implementation of guidelines in patients presenting with a fracture 
increases identification of patients at high risk for subsequent fractures and 
measures to decrease fracture risk, but its effect on prevention on the risk of 
subsequent fractures and mortality has not been documented. The aim of this 
study was to determine the impact of guideline implementation on the risk of 
subsequent fracture and mortality in patients presenting with a non-vertebral 
fracture (NVF).
Methods
Before-after impact analysis in consecutive patients older than 50 years who 
were admitted to the hospital with a NVF during 2 periods: pre-intervention 
group (n=1920, enrolled in 1999-2001) and  intervention group (n=1335, enrolled 
in 2004-2006). The intervention consisted of a dedicated fracture nurse who 
systematically offered fracture risk evaluation and treatment according to 
available guidelines. The 2-year absolute risk (AR) and hazard ratio’s (HR, with 
95% confidence interval (CI)) of subsequent NVFs and mortality were analysed 
between both groups after adjustment for age, sex and baseline fracture location 
by multivariable Cox regression and by intention-to-treat.
results 
The AR of subsequent fracture was 9.9% before and 6.7% after intervention, indi-
cating a decrease of 35% in the risk of subsequent fracture (HR 0.65; CI:0.51-0.84, 
after adjustment for age, sex and baseline fracture location) and 17.9% and 11.6%, 
respectively, for subsequent mortality, indicating a decrease of 33% in the risk 
of subsequent mortality (HR: 0.67; CI:0.55-0.81, after adjustment for age, sex and 
baseline fracture location) . 
Conclusion
Systematic implementation of guidelines for fracture prevention by a dedicated 
fracture nurse immediately after a NVF is associated with a significant reduction 
of the 2-year risk of subsequent NVF and mortality. 
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InTroduCTIon
Women and men with a history of a clinical fracture have an increased risk for 
sustaining a subsequent fracture, already within short term 1-4. Guidelines on 
osteoporosis advocate the evaluation of patients presenting with fractures for 
fracture risk, including bone densitometry by dual energy X-ray absorptiometry 
(DXA) to make appropriate decisions about therapy that has been shown to 
reduce fracture risk 5-7.  Guidelines on fall prevention advocate to perform a fall 
risk evaluation in patients with a fracture to make decisions about targeted or 
multidimensional fall prevention that has been shown to reduce fall risk 8-10. The 
Surgeon General guideline on fracture prevention promotes an integrated ap-
proach to prevent fractures, including life style advices, fall prevention and drug 
treatment if appropriate 11, 12.
However, the implementation of guidelines for osteoporosis and for falls or 
other validated case finding strategies is low in daily practice 13-24.  The reasons for 
deficient implementation of guidelines are not well defined, but are dependent 
on factors related to doctors and patients. There are several barriers against 
successful implementation, including cost of diagnosis and therapy, concerns 
about medications 13-21, 24, 25 and the lack of clarity about who is responsible for 
the osteoporosis care and patient follow-up even after a fracture has occurred 26. 
In patients presenting with a fracture, the treating surgeon or the general 
practitioner can take this responsibility, but this is often not the case 27. Today’s 
surgeons show resemblance to cardiologists about ten years ago. At that time, 
treatment focused on the treatment of the current cardiovascular (CV) event, such 
as myocardial infarction and stroke. However, no efforts were made to reduce the 
risk for subsequent CV events, even though this risk was high. After a while it 
became clear that a patient recovering from a CV event and relatives are in the 
ideal state of mind to comply with preventive advice and prescribed medication. 
Therefore, the American Heart Association (AHA) launched a program called 
“Get With The Guidelines” (GWTG). The implementation of this program immedi-
ately after an acute myocardial infarction resulted in an increased adherence to 
guidelines for secondary prevention. The goal of implementing the GWTG was 
to achieve a 25% reduction in the risk of CV events over 10 years 28. The parallel 
between cardiologists and surgeons regarding fracture care is obvious. Trauma 
and orthopaedic surgeons treating patients with fractures are responsible for 
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optimal treatment of the fracture itself, but could also initiate a procedure to 
optimize prevention of a new, subsequent fracture 29. 
The Fracture Liaison Service (FLS) has shown that systematic approach of frac-
ture patients increases case finding 24, 30-32. In addition, some data indicate that 
post-hip fracture care can decrease the risk of subsequent fracture and mortality. 
In a large prospective randomised clinical trial in 2127 patients presenting with 
a hip fracture, zoledronate with calcium and vitamin D decreased the risk of 
subsequent fractures and mortality 33. In a retrospective study in 221 patients with 
a history of hip fracture, a potential relationship was found between reduced 
mortality and post-fracture use of calcium plus vitamin D supplementation and, 
in females, concomitant use of anti-osteoporosis drugs 34.  
In patients selected on the basis of presenting with a NVF, no studies are 
available about the impact of implementing guidelines on subsequent fracture 
incidence and mortality. The aim of this pre-post intervention study was to deter-
mine the impact of guideline implementation on the risk of subsequent fracture 
and mortality in patients presenting with a non-vertebral fracture (NVF).
MeTHodS
Study design 
This study is a before-after impact analysis in two cohorts of patients. The group 
with systematic implementation of the guidelines on osteoporosis and fall 
prevention was prospectively studied and compared to a retrospective group of 
patients in the same hospital before the intervention. Both groups were com-
pared with regard of the rate of subsequent NVF and mortality. 
This study design was performed according to the Evidence-Based Medicine 
Working Group based on their conclusion that randomisation of individual pa-
tients is unlikely to be appropriate in the impact analysis of clinical decision rules 35. 
Patients 
All consecutive patients older than 50 years presenting with a NVF at the emer-
gency room and living in the postal area of Maastricht were included into two 
cohorts. Between January 1999 and December 2001, all patients were included 
in the pre-intervention group36, at the time no guidelines were available and 
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no post-fracture care was organised. Between September 2004 and September 
2006, all consecutive patients presenting with a NVF, were included.
In both groups, patients were excluded when presenting with a pathological 
fracture, a clinical vertebral fracture, or a skull fracture. For the intervention group, 
patients were excluded if they had participated in the pre-intervention group. All 
patients were included in the analysis according to the intention-to-treat (ITT) 
principle. Of the patients in the intervention group, 68.4% were evaluated. 
decision rule 
Our study was based on the Dutch guidelines on osteoporosis and falls 5, 37, 38.
Before intervention, no systematic post-fracture care was organised.
In the intervention group, a fracture nurse, trained in osteoporosis manage-
ment and fall risk assessment, contacted the patients or family with a personal 
contact 30. The aim of intervention was to evaluate subsequent fracture risk, 
to identify risk factors and to take measures to reduce fracture incidence. The 
intervention included evaluation of clinical bone related risk factors (previous 
fracture after the age of 50 years, mother with fracture history, body weight <60 
kg, severe immobility and current use of glucocorticoids), fall-related risk factors 
(more than one fall during the last year, use of psychoactive drugs, articular com-
plaints, impaired vision, urine incontinence, tests for the detection of activity of 
daily living (ADL) functions according to the Groningen Activity Restriction Scale 
(status before the fracture) 18, 39-41 and vision according to the Snellen eye chart 
41-44), bone mineral density (BMD) measurement of the femoral neck and lumbar 
spine (Hologic QDR 4500 Elite densitometer), calcium intake by a standardised 
questionnaire and vitamin D status by anamnesis (time  spent outside/day). 
Serum levels of vitamin D were not measured, as this was not advocated in the 
guideline. After evaluation, the fracture nurse instructed all participating patients 
about the need of adequate intake of calcium and vitamin D and provided gen-
eral instructions about fall prevention, adapted to the patient’s individualized fall 
risk profile. Patients were instructed to visit their general practitioner to discuss 
fall prevention strategies if the results from the fall risk assessment showed the 
patient was at high risk for falls. In addition, patients with BMD-osteoporosis were 
treated with drugs known to reduce fracture incidence, mostly a bisphosphonate 
in combination with calcium (500 mg/d) and vitamin D (400IE/d). Details about 
the initiation of medical therapy by the GP and on adherence are not available. 
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data Collection 
Baseline data on age, sex and location of baseline fracture were available in 
the pre-intervention group and were compared with the intervention group. 
All baseline and subsequent fractures were radiographically confirmed in the 
hospital database. Whether and when patients had died during follow-up was 
checked for all patients using the national obituary database.  
Fractures were classified according to the International Classification of Dis-
ease (ICD-9: clavicle, thorax, pelvis, humerus, radius and/or ulna, hand, femur, 
tibia, fibula and/or patella or foot categories). Fractures were than grouped into 
categories according to their location: major fractures (hip, pelvis, proximal tibia 
or humerus, multiple ribs and distal femur) and minor fractures (all other) similar 
to the classification of Center et al. 45.
Statistical analysis 
Baseline characteristics were compared between groups by chi-square for dichot-
omous variables and by independent samples t-tests for continuous variables. 
The absolute risk (AR) for subsequent fracture and mortality was calculated. To 
test differences in subsequent fracture incidence and mortality between groups, 
Cox regression analyses were performed with Hazard Ratio’s (HR) and 95% con-
fidence intervals (CI) regarding the ITT principle (including all patients in both 
groups in all analyses). All HRs were calculated after adjustment for age, sex and 
baseline fracture location (major vs. minor). For subsequent fractures, follow-up 
time was defined as time between first fracture and subsequent fracture, death 
or end of the study. For mortality, follow-up time was defined as time between 
first fracture and death or end of the study period. Kaplan Meier curves were 
plotted and analysed by the log rank test 33. To evaluate whether a subsequent 
fracture also had an effect on mortality, we performed the time-dependent Cox 
regression analysis with patients with a subsequent fracture as a new variable. 
Variables were considered significant if p-value was < 0.05 (two tailed). Statistical 
analysis was performed using SPSS for Windows (version 15.0; SPSS Inc. Chicago, 
IL, USA). 
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The authors did not receive any outside funding or grants in support of their 
research for or preparation of this work. Neither they nor a member of their 
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reSuLTS
In the pre-intervention group 1920 patients participated and 1335 in the interven-
tion group (Figure 1). Patients in the intervention were younger (70.8 versus 71.9 
years, p<0.05) and had more major baseline fractures (45.0 versus 40.1%, p<0.05). 
Sex distribution was similar (74.6 versus 72.5% women). Results on the effect of in-
tervention on subsequent fracture risk and mortality were therefore adjusted for 
these differences using multivariable Cox regression. All patients were analysed 
according to the ITT principle.
Subsequent fracture 
In the pre-intervention group 191 patients (9.9%) sustained a subsequent frac-
ture, and 89 patients (6.7%) in the intervention group (p=0.001) (Figure 1 and 2), 
indicating a significant fracture risk reduction of 35% (HR 0.65; 95% CI: 0.51-0.84) 
after adjustment for age, sex and baseline fracture location. 
Mortality 
By the ITT analysis, 343 patients (17.9%) deceased in the pre-intervention group 
and 155 patients (11.6%) in the intervention group (p<0.001) (Figure 1 and 2), 
indicating a significant mortality risk reduction of 33% (HR 0.67; 95% CI: 0.55-0.81) 
after adjustment for age, sex and baseline fracture location. 
The risk of mortality was increased in patients with a subsequent fracture by 
93% (HR 1.93; 95% CI: 1.41-2.64) as compared to patients without a subsequent 
fracture.  
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Figure 1 Flow chart 
Flow chart of pre-intervention group (A) and intervention group (B) divided into subsequent 
fractures and mortality within 2 years 
 
 
 
 
 
 
 
 
Figure 1. Flow chart
Flow chart of pre-intervention group (A) and intervention group (B) divided into subsequent fractures 
and mortality within 2 years
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dISCuSSIon
Systematic implementation of previously validated guidelines for osteoporosis 
and fall prevention resulted in a significant 35% reduction of subsequent frac-
ture incidence within two years and a 33% reduction in subsequent mortality, 
after adjustment for age, sex and baseline fracture location. Previous studies on 
systematic implementation of guidelines in fracture patients have shown that 
this increases identification of patients at highest risk for fractures, but they did 
not report on post-fracture outcomes 24, 32, 46-49. Zoledronate, calcium and vitamin 
D supplements given within 3 months after a hip fracture decreased the risk of 
subsequent fracture and mortality 33. Post-fracture use of calcium plus vitamin 
D supplementation and, in females, concomitant use of anti-osteoporosis drugs 
were potentially related to reduced mortality 34.  
To our knowledge this is the first study on the effect of guideline implementa-
tion on the risk of subsequent fracture and mortality in patients with a NVF. In 
spite of a lower mortality after intervention, which potentially puts more patients 
at risk for subsequent fractures, subsequent fracture risk was significantly de-
creased after intervention. 
The 35% lower subsequent fracture incidence is most probably an effect of 
several contributors including counselling, calcium and vitamin D supplements, 
drug treatment of osteoporosis and fall prevention measures. 
 
Figure 2. Kaplan Meier curves 
Figure 2A Subsequent fracture incidence within 2 years after baseline fracture between the intervention 
and pre-intervention group
Figure 2B Mortality incidence within 2 years after baseline fracture between the intervention and pre-
intervention group
Hazard ratio’s were calculated by multivariable Cox regression analysis with adjustment for age, sex and 
baseline fracture location
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The reduction in mortality is also probably an effect of several of these con-
tributors. In addition, the reduction in mortality can be partly explained by the 
reduction in overall mortality in subjects older than 50 years in The Netherlands 
during this study period from 2.7% to 2.4% 50. Therefore, further implementation 
studies will need to include population mortality background data, as has been 
done in the prospective population-based Dubbo Osteoporosis Epidemiology 
Study (DOES), in which post-fracture mortality was prospectively compared with 
mortality in subjects without fractures 51. 
Reduced mortality has been documented in a prospective randomised 
double-blind placebo-controlled study during treatment with zoledronate given 
within 3 months after a hip fracture 33. The reason for this reduced mortality 
compared to placebo is still unknown. Only 8% of this reduced mortality was 
attributable to a demonstrated effect on subsequent fracture risk reduction 52. 
However, our results and those of the zoledronate study, indicate that measures 
to prevent fractures also reduce mortality. This finding strengthens the view that 
post-fracture care does not only have an effect on subsequent fracture risk, but 
also on other adverse outcomes like mortality.      
This study has several limitations. Firstly, 31.6% of patients did not want to par-
ticipate in the intervention program. This might be because the non-responders 
were older and sustained significantly more major fractures, including hip 
fractures. Several studies showed that only 50-85% of the patients at high risk of 
an osteoporotic fracture participate in a prevention program 47 53 32 and that com-
pliance regarding the intake of prescribed drugs is suboptimal 54. The reduction 
of subsequent fracture and mortality risk could be demonstrated by ITT which 
included all patients, also those who did not fully participated in the intervention. 
Thus, even with 68.4% of the patients of the intervention group participating in 
the intervention, as in our study, a risk reduction could be demonstrated after 
adjustment for age, sex and baseline fracture location. However, implementation 
of a fracture prevention program by a specialised nurse will probably not reach 
the optimal result until the issue of non-response (about one third of patients 
with a NVF) will be resolved. 
Secondly, the external validity of this approach needs broad verification. In a small 
study we have already shown that case finding using DXA is 10-fold higher than in 
the surrounding hospitals without a fracture nurse 55. This confirms that the pres-
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ence of a fracture nurse increases case finding24 32 ,but no comparison is currently 
available about the two-year fracture incidence in these surrounding hospitals 55. 
Thirdly, due to the study design, it is not possible to point out which components 
of the intervention contributed to this effect and to what degree. Changes in other 
components of post-fracture care (anaesthesia, wound healing care) or improved 
post-fracture care by physicians who applied the guidelines could be involved. 
Fourthly, an impact study would ideally be a randomised study with and 
without application of guidelines. However, randomisation of individual patients 
is unlikely to be appropriate because it is expected that participating clinicians 
incorporate the guidelines into the care of all patients, and it would be consid-
ered unethical to withdraw treatment in the presence of existing guidelines for 
subsequent fracture prevention. A well-accepted design for implementation of 
guidelines in cardiovascular studies is the pre- post-intervention study design, 
which we therefore have applied in this study 35. 
Fifthly, the pre- and post intervention groups differed slightly in age and base-
line fracture locations. However, this could be resolved by using multivariable 
Cox regression with adjustments for these variables. 
We conclude that systematic implementation of guidelines for osteoporosis 
and fall prevention, by a dedicated fracture nurse, shortly after a NVF is associated 
with a significant risk reduction of subsequent fractures and mortality. Therefore, 
we suggest implementation of such guidelines in services taking care of patients 
with a recent NVF. Further studies are needed to analyse which components of 
the intervention are most effective or whether it is the combination of bone 
and fall-related evaluation and intervention that is contributing to fracture and 
mortality reduction. 
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aBSTraCT
Introduction
A systematic Fracture Liaison Service (FLS) model of care is widely recommended 
and applied, but data are scarce on its effectiveness. Therefore, the risk of subse-
quent non-vertebral fractures and mortality within 2 years after a non-vertebral 
fracture was analysed in patients who attended a hospital with FLS and a hospital 
without FLS. 
Methods 
In 2005-2006, all consecutive patients older than 50 years presenting with a 
non-vertebral fracture were included.  In the no-FLS, only standard fracture care 
procedures were followed to address proper fracture healing. In the FLS, DXA 
and laboratory testing were performed, and if applicable, patients were treated 
according to the Dutch guideline for osteoporosis. The risk for subsequent 
non-vertebral fracture risk and mortality was analysed using multivariable Cox 
regression models with adjustments for age, sex and baseline fracture location.
results 
In total, 1412 patients attended the FLS (73.2% women, mean age: 71.1 years) and 
1910 underwent standard fracture care (no FLS, 69.8% women, mean age: 69.5 
years). After adjustment for age, sex and baseline fracture location, patients 
who attended the FLS had a significantly lower mortality risk (Hazard Ratio (HR): 
0.65, 95%CI: 0.53-0.79) over 2-years of follow-up. The subsequent non-vertebral 
fracture risk was also significantly lower in FLS patients, but this effect was time-
dependent with at 12 months a HR of 0.84 (95%CI: 0.64-1.10) and at 24 months of 
0.44 (95%CI: 0.25-0.79). 
Conclusion
Patients who attended the FLS had a significant lower mortality and subsequent 
non-vertebral fracture risk over 2-years follow-up, 35% and 56% respectively. 
Therefore, FLS might be a successful approach to reduce the number of subse-
quent fractures and premature mortality. 
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InTroduCTIon
Patients with a fracture after the age of 50 years are at increased risk of sustaining 
a subsequent fracture, which is highest at short term after the initial fracture (<2 
years) 1-8. Fracture Liaison Services (FLSs) have been developed and implemented 
to identify, evaluate and treat patients with a recent fracture 9, but they differ in 
the way they identify, assess and treat individuals at high risk of a subsequent 
fracture 10-12. Patients with a recent fracture not only have an increased risk of 
subsequent fracture, but also an increased risk of mortality especially after hip 
and major fractures 13, 14. In addition to fracture prevention, recent studies indi-
cated that mortality could also be reduced by bisphosphonate treatment. A 28% 
reduction in mortality was reported after zoledronic acid therapy in patients with 
a recent hip fracture and a life expectancy of more than 6 months 15. A significant 
reduction in mortality of 11% was found in a recent meta-analysis on the effect of 
osteoporosis medication on mortality 16, 17. 
In a previous before-after impact study (1999-2001 vs. 2004-2006), the 2-year 
risk reduction of repeat non-vertebral fracture and mortality was 35% and 33%, 
respectively 18. However, it could not be ruled out that other components of post-
fracture care had changed over time.
Therefore, the aim of the current study was to evaluate the impact of the FLS 
by comparing subsequent non-vertebral fracture risk and mortality between two 
hospitals within the same years, one with and one without a FLS, over a two-year 
follow-up period in patients who presented with a non-vertebral fracture. 
MaTerIaL and MeTHodS
Study design
This prospective study was conducted in two hospitals in the Netherlands: one 
university hospital with a FLS and one general hospital without a FLS (“no-FLS”). 
In the FLS, a dedicated fracture nurse systematically evaluated all patients aged 
50 years and over, who were able and willing to participate, at the outpatient 
clinic after a recent NVF. 
The fracture nurse checked whether all patients >50 years with a fracture had 
an appointment at the FLS using the Emergency Department computer system. 
106 Chapter 7
If not, she sent an invitation by mail. All fracture patients were seen at the fracture 
outpatient clinic by an orthopaedic trauma surgeon. The evaluation consisted 
of a systematic evaluation of clinical risk factors (medical history, exposure to 
medication and fall-related risk factors. The clinical and fall-related risk factors 
are published elsewhere 19. Additionally, the Groningen Activity Restriction Scale 
(GARS) was used to estimate the disability in activities of daily living (ADL)10, 12, 20. 
Bone mineral density (BMD) measurement of the femoral neck and lumbar spine 
was assessed using a Hologic QDR 4500 Elite densitometer. All patients with a 
T-score equal or less than -2.5 SD at either BMD location were advised to start 
treatment according to the Dutch osteoporosis guideline 10, 20. The evaluation 
consisted of two appointments: in the first one the FLS is explained and informed 
consent is obtained; and in the second one all risk factors and DXA results were 
collected. Based on the results, the fracture nurse informs the patient and advices 
to start treatment when necessary (anti-osteoporosis, calcium and vitamin D).
In the no FLS group patients received standard fracture care concentrated on 
the fracture healing, not on the possible predisposing factors. 
All consecutive patients older than 50 years and living in the postal area of the 
FLS and no-FLS hospital that presented with a recent non-vertebral fracture in 
2005 and 2006 were included in the study. Patients with pathological or verte-
bral fractures were excluded. Baseline and subsequent fractures were classified 
according to the ICD-9 International Classification of Disease and additionally 
categorised based on fracture location as hip, major (pelvis, proximal tibia or 
humerus, multiple ribs and distal femur) and minor (all remaining fractures) 13. 
These categories were chosen, because hip and major fractures are associated 
with increased mortality 1, 13. Mortality was obtained and confirmed using the 
national obituary database. Date, but not cause of death is registered in this da-
tabase. According to the intention-to-treat principle, patients who were unable 
or not willing to visit the FLS were included in the FLS group and in all analyses. 
Statistical analysis
Characteristics between FLS and no-FLS were analysed with Pearson’s chi-square 
test for dichotomous variables and independent-samples T-test for continuous 
variables. The effect of FLS on subsequent fracture and mortality was analyzed 
using multiple Cox proportional hazard models. For the death-censored analyses 
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of subsequent fracture, follow-up time was set as time between the first and 
subsequent fracture, death or end of 2-year follow-up period. For the analysis 
with mortality as event, follow-up time was set as time between first fracture and 
death or end of the 2-year study period. 
The proportional hazard (PH) assumption was checked using Schoenfeld resid-
uals. If this assumption was violated, i.e. the hazard ratio (HR) is not constant over 
time, time-dependent Cox proportional hazard models were used. Subgroup 
analyses, i.e. multiple Cox PH regression, were performed for baseline fracture 
location and in a subgroup comparing no-FLS with FLS (divided into “shows” 
Figure 2 Subsequent fracture incidence
a1 and B1 Cumulative survival rate with subsequent fractures as event for the patients included at the 
university hospital with a Fracture Liaison Service (FLS; black line) and at the general hospital without a 
FLS (no-FLS; grey line)
a1: all fractures, B1: baseline hip fractures
a2: Hazard ratio’s (continuous black line) and 95% confidence intervals (95% CI, black dotted lines) for 
subsequent fractures as event: comparing patients included at the university hospital with a Fracture 
Liaison Service (FLS) and at the general hospital without a FLS (no-FLS). After 15 months (HR: 0.72, 95% CI: 
0.52-0.98) subsequent fracture hazard rate was significantly lower in the FLS. 
B2: Hazard ratio’s (continuous black line) and 95% confidence intervals (95% CI, black dotted lines) for 
subsequent fractures as event for the subgroup with a baseline hip fracture: comparing patients included 
at the university hospital with a Fracture Liaison Service (FLS) and at the general hospital without a FLS 
(no-FLS). After 13 months (HR: 0.43, 95%CI: 0.20-0.94) subsequent fracture hazard rate was significantly 
lower in the FLS.
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and “no-shows”). All analyses were performed with adjustments for sex, age and 
baseline fracture location, except the subgroup analyses in which adjustments 
were made for sex and age.. All statistical analyses were performed using SPSS 
software 18.0 for Windows (SPSS Inc., Illinois, USA). MathLab (7.10) was used to 
plot figures 2A2 and 2B2.
Source of funding
The authors declare that no external funding source played a role in this inves-
tigation. 
reSuLTS
Patient characteristics
In total, 3322 patients (1412 FLS and 1910 no-FLS) were included of whom 71.3% 
were women (Figure 1). Differences in patient characteristics between FLS and 
no FLS patients are shown in Table 1. Of the 1412 patients in the FLS hospital, 
67.8% participated in the FLS (shows FLS). Within the FLS group, the “no shows” 
(patients not willing or able to participate) were significantly older (76.9 years 
vs. 68.3 years, p<0.001) and had sustained more hip fractures (34.1% vs. 13.1%, 
p<0.001) than the “shows”. 
Subsequent non-vertebral fractures
In total, 225 (6.8%) patients sustained a subsequent non-vertebral fracture within 
two years after their baseline non-vertebral fracture; 130(6.8%) in the FLS and 95 
(6.7%) in the no-FLS hospital (Figure 1). After adjusting for sex, age and baseline 
Baseline variable FLS no-FLS Total P-value
Women (n, %) 1033 (73.2) 1334 (69.8) 2367 (71.3) 0.037
age (mean years, Sd) 71.1 (11.8) 68.3 (11.0) 69.5 (11.4) <0.001
Baseline fracture location (n, %)b Hip 280 (19.8) 303 (15.9) 583 (17.5)
<0.001Major 298 (21.1) 357 (18.7) 655 (19.7)
Minor 834 (59.1) 1250 (65.4) 2084 (62.7)
Table 1. Baseline characteristics of patients included at the university hospital with a 
Fracture Liaison Service (FLS) and at the general hospital without a FLS (no-FLS).a
a . Chi-square tests and Student T-tests were used. 
b  Major: pelvis, proximal tibia or humerus, multiple ribs and distal femur; Minor (all other fractures)
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fracture location, the general Cox PH model showed no significant difference in 
subsequent fracture risk between the FLS and no-FLS patients (HR: 0.88, 95% 
confidence interval (95%CI): 0.67-1.14) (Table 2, and Figure 2A1).
However, since the assumption of PH was violated for FLS vs. no-FLS, the time-
dependent Cox model should be applied instead of the general Cox model. There 
were no significant lower subsequent fracture risk in the FLS compared with the 
 
 
 
 
 
 Figure 1. Flow chart 
Flow chart of patient categories over a 2-year follow-up period for the university hospital with a Fracture 
Liaison Service (FLS) and at the general hospital without a FLS (no-FLS).
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no-FLS after 6 months and 12 months follow-up, but there was  from 15 months 
onwards (HR at 15 months: 0.72, 95% CI: 0.52-0.98; Table 2, Figure 2A2). 
The subgroup analyses according to baseline fracture location showed no 
significant difference in subsequent non-vertebral fracture risk between FLS and 
no-FLS (Table 2, Figure 2B1). 
However, for the hip fracture subgroup, the PH assumption was violated. The 
results of the time dependent Cox model showed no significant differences be-
tween the FLS and no-FLS at 6 months and 12 months follow-up However, from 
13 months onwards the risk was significantly lower in the FLS group (HR: 0.43, 
95%CI: 0.20-0.94), and remained lower during follow-up, Figure 2B2; Table 2).
Multivariable
(Hr; 95%CI)
Time 
dependency
Multivariable
(Hr; 95%CI)
Multivariable
(Hr; 95%CI)
Multivariable
(Hr; 95%CI)
Multivariable
(Hr; 95%CI)
6
months
12
months
18
months
24
months
FLS vs no-FLS * 0.88
(0.67-1.14)
Yes 1.15
(0.85-1.60)
0.84
(0.64-1.10)
0.61
(0.42-0.90)
0.44
(0.25-0.79)
Baseline hip 
# **
0.63
(0.34-1.18)
Yes 1.16
(0.53-2.55)
0.50
(0.24-1.04)
0.21
(0.07-0.65)
0.09
(0.02-0.48)
Baseline 
major #
0.89
(0.51-1.56)
No
Baseline 
minor #
0.98
(0.69-1.34)
No
Multivariable
(HR; 95%CI)
Time 
dependency
FLS vs no-FLS 0.65
(0.53-0.79)
No
Baseline hip # 0.67
(0.49-0.91)
No
Baseline 
major #
0.57
(0.37-0.89)
No
Baseline 
minor #
0.74
(0.51-1.07)
No
Table 2. Multivariable Cox regression analysis on subsequent fracture incidence and 
mortality between FLS and no-FLS
FLS vs no-FLS adjusted for age, sex and baseline fracture location
Subgroup analyses (hip, major, minor) adjusted for age and sex
* significant at 15 months (HR 0.72 (0.52-0.98)) (See also figure 2)
** significant at 13 months (HR 0.43 (0.20-0.94)) (See also figure 2)
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A subgroup analysis comparing no-FLS with FLS (divided into “shows” and 
“no-shows”) showed no overall significant difference on subsequent fracture 
incidence (p=0.085).
Mortality
In total, 396 patients (11.9%) died within 2 years (Figure 1) of whom 162 (11.5%) 
were FLS-patients and 234 (12.3%) were no-FLS patients.
The PH assumption was not violated for mortality. Mortality risk was signifi-
cantly lower in the FLS than the no-FLS hospital (Table 2, Figure 3A). Significant 
interaction was found between FLS and sex. Separate analyses for sex showed that 
women in the FLS group had a significantly lower mortality risk (HR: 0.57; 95%CI: 
0.44-0.73). In men the difference was not significant (HR: 0.81; 95%CI: 0.57-1.16). 
The subgroup analyses according to baseline fracture locationshowed that 
mortality risk was significantly lower in the FLS l after baseline hip fracture 
and after baseline major fracture, with a similar but not significant trend after 
baseline minor fracture (Table 2, Figure 3B-C). Again, the PH assumption was not 
violated. A subgroup analysis comparing FLS (divided into “shows FLS” and “no-
shows FLS”) and no-FLS indicated that the mortality rate was significant lower in 
the patients that attended the FLS (shows) compared to no-shows FLS (HR: 0.42; 
95%CI: 0.30-0.60) and no-FLS (HR: 0.40; 95%CI: 0.29-0.54). This effect was mainly 
driven by baseline hip fracture (HR hip vs. minor: 2.80; 95%CI: 2.18-3.58, and HR 
hip vs. major: 1.64; 95%CI: 1.27-2.13). 
Figure 3 Mortality incidence 
Cumulative survival rate with mortality as event for the patients included at the university 
hospital with a Fracture Liaison Service (FLS; black line) and at the general hospital without a 
FLS (no-FLS; grey line).  
A: all fractures, B: baseline hip fractures and C: baseline major fractures 
Figure 3. Mortality incidence
Cumulative survival rate with mortality as event for the patients included at the university hospital with a 
Fracture Liaison Service (FLS; black line) and at the general hospital without a FLS (no-FLS; grey line). 
a: all fract , : li e hip fractures and C: baseline major fractures
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dISCuSSIon
In this study we compared subsequent fracture incidence and mortality rate 
in patients who had presented with a non-vertebral fracture over two years of 
follow-up between two hospitals; one with and one without a Fracture Liaison 
Service. There was a significant time-related lower subsequent non-vertebral 
fracture incidence after correction for age, sex and baseline fracture location 
in patients evaluated and treated according to the Dutch guidelines of 2002 on 
osteoporosis in the FLS compared to the no-FLS hospital. (CME) No significant 
difference in fracture rate was found during the first year, but from the second 
year on fracture incidence was 28% lower at 15 months and 56% lower at 2 years. 
These data are consistent with our previous results that showed an overall lower 
subsequent non-vertebral fracture incidence of 35% after the introduction of a 
FLS as compared to 5 years earlier without a FLS 18. Subgroup analysis according 
to baseline fracture indicated that the time-dependent effect on subsequent 
non-vertebral fractures was mainly driven by the effect in patients with a baseline 
hip fracture, since subsequent non-vertebral fracture incidence was 57-91% lower 
after a hip fracture in the FLS group, without differences after baseline major or 
minor non-vertebral fractures. 
Mortality rate was 35% lower in the FLS compared to the no-FLS group after 
correction for age, sex and baseline fracture location. The difference in mortal-
ity was not time dependent. Based on subgroup analysis according to baseline 
fracture location, significant differences were found after baseline hip (-33%) and 
major fractures (-43%), but not after minor fractures. 
Remarkably, fewer patients died in the FLS group, therefore more patients 
survived to be at risk for a subsequent fracture but still there was a significant 
reduction of subsequent non-vertebral fractures in the second year of follow-up. 
Also, despite the fact that patients in the no-shows FLS group were older, had 
more hip fractures at baseline and more risk factors for subsequent fractures and 
mortality, we found a lower incidence in mortality and subsequent fractures (in 
the second year) for the total FLS group compared to the no-FLS group. Previous 
studies showed similar results on subsequent fracture risk and mortality 1, 2, 5, 13, 14. 
A recent study showed in patients 60+ years a relative risk (RR) in women of 1.95 
and 3.45 of men in subsequent fracture incidence 1. Two retrospective studies 
showed an absolute risk of subsequent fractures of 10.8% in 2-year follow-up 
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and 17.6% in 5-year follow-up of all fracture patients older than 50 2, 5. Fractures 
increased the risk of mortality, especially after a hip fracture, e.g. 13. Another study 
showed increased mortality risk after all types of fragility fractures that was high-
est within the first five years of follow-up 14. However, in none of these studies 
was the outcome of patients in a FLS versus no-FLS hospital was compared. The 
findings in the present study strongly support the concept that a Fracture Liaison 
Service can reduce both fractures and mortality 21.  
Many Randomized Controlled Trials (RCTs) have included patients with a 
prevalent vertebral fracture of unknown date with and without BMD criterion. In 
these studies a reduction of subsequent hip, non-vertebral fracture and vertebral 
fracture has been shown, depending on treatment. 
Only one RCT has demonstrated mortality reduction after treatment compar-
ing yearly administration of the intravenous bisphosphonate, zoledronic acid, 
in patients with a recent hip fracture compared to placebo 15. In that study, a 
subgroup of patients with a recent hip fracture was included who had, according 
to the investigator, a life expectancy of more than 6 months and without BMD 
restrictions. It was the first RCT in which an effect on mortality was demonstrated. 
Mortality decreased from 16 months on and when the first zoledronic acid infu-
sion was given from 4-6 weeks after the hip fracture. In contrast, we found a lower 
mortality rate, which was independent of time. 
Several studies have meanwhile shown that anti-osteoporosis treatment can 
not only decrease fracture rate and increase in quality of life, but also decrease 
mortality. In a meta-analysis of bisphosphonate RCTs, mortality was 11% lower 
than in placebo 16. Oral bisphosphonates in hip fracture patients showed a 27% 
reduction in mortality compared to non-users 22. In a 3-year prospective study in 
220 patients with a recent hip fracture, mortality was 60% lower in each year in 
patients with a T-score <-1.5 who received bisphosphonates 23. In a prospective 
cohort study, treatment with bisphosphonates was associated with 69% reduc-
tion in mortality rate during longitudinal follow-up 17. 
The mechanisms by which mortality is reduced are still unclear and seem to be 
multifactorial and probably related to extra skeletal effects of bisphosphonates 
17 or calcium and vitamin D or other still unclear mechanisms. One explanation 
could be the prevention of (subsequent) fractures. In our previous research pa-
tients with a subsequent fracture had a higher risk of mortality after subsequent 
fracture compared to patients without a subsequent fracture 14, 18. However, 
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fracture prevention seems only to have a small attribution in mortality reduction. 
In the intravenous bisphosphonate RCT study, 8% of the overall 28% mortality 
reduction could be attributed to fracture risk reduction 24. Vitamin D insufficiency 
is associated with osteoporosis and seems to be associated with other medical 
conditions. A recent study evaluated anti-osteoporotic treatment in hip fracture 
patients in a nationwide database and found an association between anti-
osteoporotic treatment, vitamin D and calcium supplements and reduced post 
hip fracture mortality of 38% in women25. In men this reduction was 26% and only 
seen after vitamin D and/or calcium supplements 25. Another positive effect on 
the patient’s overall health and thereby reduce mortality might be the attention 
of the fracture nurse to the fracture patient. Unfortunately, we only have data on 
subsequent fractures, mortality, sex, age and fracture location and therefore we 
cannot measure this possible positive effect. 
The lower mortality in the FLS group in our study can only be partly explained 
by treatment with bisphosphonates and calcium and vitamin D, since only a 
limited number of patients were on bisphosphonate therapy, which was given 
to the participating patients who had BMD defined osteoporosis (approximately 
50%). We do not have data about the percentage of patients treated with anti-
osteoporosis medication in the no-FLS group, but post-fracture treatment and 
persistence of treatment at the time of this study was known to be low 26. 
A strength of our study is that all consecutive patients that presented with a 
non-vertebral fracture in both hospitals were included in the analysis according 
to the intention-to-treat principle. The lower fracture and mortality rate was 
found in the total FLS group, in spite of inclusion of no-show patients who were 
significantly older and had more base-line hip fractures. A limitation of this study 
is that it is not a randomized controlled trial. Therefore other possible confound-
ers could not be ruled out especially since we do not have additional information 
about management in the no-FLS group. Also baseline differences between the 
groups on sex, age and baseline fracture location is a limitation of this study, but 
we adjusted the cox regression analyses for these known factors. Cox regression 
analyses adjusted for age, sex and baseline fracture location showed a time-
dependent effect (Figure 2), whereas the absolute risks were comparable (6.7% 
and 6.8%, respectively). The difference in conclusion is due to the fact that there 
is a time-dependent factor, which is not taken into account in an absolute risk 
analysis. More specifically, the effect of the FLS is more pronounced after one year 
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than during the first months. This is probably due to the effect of bone directed 
therapies (calcium, vitamin D and bisphosphonates) and therapies directed at 
SECOB (secondary osteoporosis and metabolic bone diseases). The intervention 
will continue after the visit at the FLS and was not the standard of fracture care 
in the non-FLS hospital.
In the Netherlands, BMD measurements and outpatient clinic visits are always 
covered by health care insurance. However, travel costs and parking tickets are 
not reimbursed. Recent cost-effectiveness analyses showed that FLSs are cost-
effective in fragility fracture patients for prevention of further fractures 27, 28. The 
ASBMR Task Force published recently an article about making the first fracture 
the last 29. The authors concluded that the FLS was the most important tool for 
such a change in fracture patients and that implementation would still be chal-
lenging in some ways 29.  
In conclusion, patients with a recent non-vertebral fracture who were evalu-
ated at the hospital with a FLS had a significantly lower mortality compared to 
patients in a no- FLS hospital. Subsequent fracture risk was significantly lower 
after 15 months and decreased by up to 56% after 2 years follow-up in the pa-
tients evaluated at the FLS hospital. These results indicate that a FLS should be 
considered in patients with a recent fracture, especially after a recent hip or other 
major fracture.
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In the field of post fracture care there has been substantial progress in identify-
ing and recognizing patients at high-risk for subsequent fracture. In this context, 
there is increasing evidence that a dedicated fracture nurse under supervision of 
surgeons, rheumatologists or endocrinologists, can integrate osteoporosis and 
fall prevention guidelines at the Fracture Liaison Service (FLS). In this thesis, we 
studied in patients with a recent non-vertebral fracture the timing and risk factors 
for subsequent non-vertebral fracture and mortality, and compared subsequent 
fracture risk and mortality risk before and after the introduction of the FLS.
ParT I SuBSeQuenT FraCTure InCIdenCe In PaTIenTS WITH a 
reCenT FraCTure
The first aim of this thesis was to evaluate the subsequent non-vertebral fracture 
incidence in patients with a recent non-vertebral fracture. Therefore, in chapter 
2 we retrospectively investigated a cohort of fracture patients of 50+ years of age 
who had sustained a recent non-vertebral fracture. The absolute risk for a subse-
quent non-vertebral fracture within 5 years was 17.6%, and increasing age was 
Mortality and fractures after initial hip or hand/foot 
fracture (5 yrs follow-up) 
9% 
8% 
27% 56% 
1st hip fracture (n=469) 
2nd fracture,
alive
2nd fracture,
died
Alive, no 2nd
fracture
Died, no 2nd
fracture
15% 
3% 
74% 
8% 
1st hand/foot fracture (n=263) 
Absolute fracture risk 
In all: 
      17%           18% 
        in survivors: 
      40%           20% 
Figure 1.
Subsequent fracture incidence and mortality according to baseline fracture location.
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a significant risk factor (Figure 1). The absolute risk for mortality was 32.3%, with 
increasing age, male sex, an initial major fracture (hip, pelvis, multiple ribs, proxi-
mal tibia/humerus and distal femur) and a subsequent fracture as significant risk 
factors. We also found a time-related effect: the risk of sustaining a subsequent 
fracture, as well as mortality, was highest immediately after the non-vertebral 
fracture. After multivariable analyses, patients with a minor fracture had a similar 
risk for sustaining a subsequent fracture compared to patients with an initial 
major fracture, but the risk for premature mortality was highest for patients with 
an initial major fracture. From a clinical point of view these results indicate that 
fracture prevention should be considered after any non-vertebral fracture and, 
moreover, starting immediately after the initial fracture. Still, there is the need to 
study which reversible factors can be targeted to prevent subsequent fractures 
and mortality.  
In chapter 3, we reviewed studies that focused on the timing of repeat fractures, 
i.e. the time of subsequent fracture after an initial fracture. The RR of fractures 
is doubled after a fracture, but this meta-analysis could not take into account 
the timing of subsequent fractures, as this was not available in the included 
population-based studies1. However, studies that noted the timing of fractures 
indicate clustering of fractures in time, i.e. the risk of subsequent fracture is high-
est in the first years following a fracture and decreases over time after a fracture. 
This has been shown for repeat radiographic and clinical vertebral fractures, re-
peat hip fractures and repeat low-trauma fractures, and for fractures after clinical 
vertebral fractures and after hip fracture. 
The results of a population-based study in postmenopausal women in the 
South of the Netherlands showed that the risk for any initial fracture was 1% per 
year, and the subsequent risk of any subsequent fracture was highest within the 
first year (absolute risk: 6%) and this declined exponentially (absolute risk over 20 
years: 40%). Focusing only on the patients who sustained a subsequent fracture, 
23% of all subsequent fractures occurred within the first year and 54% within 5 
years after the initial fracture. However, after 15 years, the subsequent fracture 
risk was no longer higher than the initial fracture risk2 (Figure 2).  
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Figure 2 
Clustering of fractures in time, especially within the first years. 
 
The clustering of fractures in time indicates the need for immediate attention to fracture 
patients, in order to prevent the occurrence of a subsequent fracture. When treatment with 
osteoporosis medication is considered, such treatment should be chosen on the basis of 
proven short-term efficacy in the reduction of fractures. 
 
In conclusion, the results of part I of this thesis showed that almost one in five patients with 
a recent non-vertebral fracture sustained a subsequent fracture within five years of follow-
up. We found that most of the fractures occurred within the first year after the initial 
fracture, in concordance with recent literature. In addition, mortality was also highest within 
the first year after the initial fracture. Therefore, immediate action after the initial fracture is 
necessary to reduce the risk of a subsequent fracture.   
Part II  Fracture Liaison Service: risk evaluation 
The second aim of this thesis was to evaluate the possible benefit of implementation of a 
guideline on osteoporosis and falls combined into a Fracture Liaison Service by a dedicated 
fracture nurse. The FLS has shown that systematic approach of fracture patients increases 
case identification3-5.    
 
In chapter 4, we analyzed risk factors in patients with a recent non-vertebral fracture over 2 
years of follow-up. The hypothesis was that patients with a non-vertebral initial fracture 
with both bone- and fall-related risk factors were at higher risk of sustaining a subsequent 
non-vertebral fracture and premature mortality even if they were offered fall and fracture 
Figure 2.
Clustering of fractures in time, especially within the first years.
The clustering of fractures in time indicates the need for immediate attention to 
fracture patients, in order to prevent the occurrence of a subsequent fracture. 
When treatment with osteoporosis medication is considered, such treatment 
should be chosen on the basis f ro en short-term effica y in the reduction of 
fractures.
In conclusion, the results of part I of this thesis showed that almost on  in five 
patients with a recent non-vertebral fracture sustained a subsequent fracture 
within five years of follow-up. We found that most of the fractures occurred within 
the first year after the initial fract re, in concordance wit  recent literature. In 
addition, mortality was also highest within the first year after the initial fracture. 
Therefore, immediate action after the initial fracture is necessary to reduce the 
risk of a subsequ nt fracture.  
ParT II  FraCTure LIaISon SerVICe: rISK eVaLuaTIon
The second aim of this thesis was to evaluate the possible benefit of implementa-
tion of a guideline on osteoporosis and falls combined into a Fracture Liaison Ser-
vice by a dedicated fr cture nurse. The FLS has shown that systematic approach 
of fracture patients increases case identification3-5.   
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In chapter 4, we analyzed risk factors in patients with a recent non-vertebral 
fracture over 2 years of follow-up. The hypothesis was that patients with a 
non-vertebral initial fracture with both bone- and fall-related risk factors were 
at higher risk of sustaining a subsequent non-vertebral fracture and premature 
mortality even if they were offered fall and fracture prevention according to the 
Dutch fracture- and fall-prevention guidelines6-8. Of all patients, 51% had at least 
one bone-related risk factor and 60% at least one fall-related risk factor. Univari-
able Cox regression analysis showed a 99% higher risk in subsequent fracture risk 
in patients with the combination of bone- and fall-related risk factors compared 
to all other patients. In multivariable analyses (including age, gender and baseline 
fracture location) this tendency was also shown, but it did not reach statistical 
significance. We also found a time-dependent effect in patients with the combi-
nation of risk factors compared with patients with only bone-related risk factors. 
Immediately after their initial non-vertebral fracture, patients with the combina-
tion of bone- and fall-related risk factors had a higher subsequent fracture risk 
until approximately 8 months after their non-vertebral fracture. However, a study 
with a larger number of events is necessary to confirm our findings. In univariable 
analysis, patients with the combination of bone- and fall-related risk factors had 
a significantly higher risk for a subsequent fracture compared to patients with 
only fall-related risk factors (Hazard Ratio (HR) 2.41; 95% Confidence Interval (CI) 
1.06-6.46), but not in multivariable analysis. These data indicate that, in spite of a 
FLS assessment, patients with a combination of bone- and fall-related risk factors 
still had a high fracture risk at short term. No difference was found between the 
groups on mortality rate. Possible explanations could be the low event rate in our 
study or the treatment with bisphosphonates, which might reduce mortality. The 
mechanism still remains unclear and could be its effect on subsequent fracture 
risk or on extraskeletal sites9-11. 
An evaluation of FLSs allowed identifying similarities and differences in the 
performance of evidence-based medicine and prevalence of clinical risk factors. 
Also, it can be helpful to detect strengths and weaknesses of guideline advices 
and their implementation. 
In chapter 5 we aimed to identify similarities and differences in the perfor-
mance and the prevalence of clinical risk factors in patients presented at a FLS in 
five large hospitals in the Netherlands. We hypothesized that the FLSs would all 
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select patients based on guideline on osteoporosis and fracture prevention by 
the Dutch Institute for Healthcare Improvement7. In total 7,199 patients aged 50 
years and over with a recent non-vertebral fracture were prospectively followed 
over a period of 39-58 months. Of the 7,199 patients, 76.7% were women and the 
mean age was 66.7 years. There was a significant difference in the prevalence of 
reported clinical risk factors between the FLSs. Variability expressed as relative 
risks between the clinical risk factors ranged from 1.7 (previous vertebral fracture) 
to 37.0 (corticosteroids usage), depending on the risk factor. We concluded that 
a dedicated fracture nurse was the central responsible coordinator to identify 
fracture patients to evaluate risk factors for subsequent fractures and to organize 
secondary fracture prevention after counseling by the (orthopedic) surgeon, 
endocrinologist or rheumatologist. Also, we found that there was a striking 
difference in the prevalence of clinical risk factors and fall risks between the el-
derly screened for osteoporosis. This indicates that prevention strategies to avert 
subsequent fractures mainly have to focus on bone mineral density, clinical risk 
factors for osteoporosis and fall risks and potentially there are differences in the 
presence of risk factors between different fracture types. 
In conclusion, in part II of this thesis we demonstrated that in patients with a re-
cent non-vertebral fracture evaluated and treated at the FLS 51% had at least one 
bone-related risk factor and 60% had at least one fall-related risk factor. Patients 
with the combination of both had a 99% higher risk of sustaining a subsequent 
fracture within 2-years after their initial fracture. Also a time-dependency was 
seen in patients with the combination of risk factors compared to patients with 
only a bone-related risk factor in timing of subsequent fracture incidence. In an 
evaluation of five FLSs throughout the Netherlands we found that a dedicated 
fracture nurse was the central responsible coordinator of this outpatient clinic. 
The assumption that all hospitals would strictly select the patients based on 
the guideline on osteoporosis and fracture prevention of the Dutch Institute for 
Healthcare Improvement, might not be correct, since differences were found in 
the performance of patient selection, clinical risk factors and prevalence of clini-
cal risk factors, indicating the need for more concrete and standardized guide-
lines to organize evaluation of patients at the time of fracture in daily practice. 
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ParT III FraCTure LIaISon SerVICe: rISK reduCTIon?
The third aim of this thesis was to investigate whether the implementation of a 
FLS could lower the risks on subsequent fracture incidence and mortality. 
In chapter 6, we conducted a prospective cohort study of patients of 50+ years 
of age with a recent non-vertebral fracture treated at the FLS in the Maastricht 
University Medical Center. To assess whether a FLS with a dedicated fracture 
nurse could have a beneficial effect on subsequent fracture incidence and 
mortality we compared this patient cohort with a retrospective cohort of frac-
ture patients treated in the same hospital (a so-called pre-post analysis). These 
patients received usual care and were treated before the implementation of the 
FLS. We found that systematic implementation of previously validated guidelines 
for osteoporosis and fall prevention resulted in a significantly lower incidence of 
subsequent non-vertebral fractures by 35% in two years, and a 33% lower inci-
dence in mortality6, 7. The lower incidence of subsequent fractures is most prob-
ably a multifactorial effect, including counseling, increased patient awareness, 
calcium and vitamin D supplements, drug treatment of osteoporosis and fall 
prevention measures. The reduction in mortality could only partly be explained 
by the lower subsequent fracture incidence, as seen by others11. This suggests 
that post-fracture care does not only have an effect on subsequent fracture risk, 
but also on other adverse outcomes like mortality. Changes over time in other 
components of post-fracture care (anesthesia, wound healing care), or improved 
post-fracture care by physicians who applied the guidelines could be related to 
the observed results. 
Therefore, in chapter 7, we investigated the subsequent fracture incidence and 
mortality in a pre-specified group of fracture patients. We included all patients 
with a recent non-vertebral fracture between 2004-2006 in a hospital with and 
in a hospital without a FLS. In the no-FLS hospital, only standard fracture care 
procedures were followed to address proper fracture healing. In the FLS hospital, 
Dual-energy X-ray Absorptiometry scan (DXA-scan) and laboratory testing were 
performed. In total, 1412 patients attended the FLS and 1910 underwent standard 
fracture care. Patients treated at the FLS hospital had a significantly lower, time-
related incidence of a subsequent non-vertebral fracture after correction for age, 
8129Summary and conclusions
sex and baseline fracture location. No significant difference in fracture rate was 
found within the first year, but from the second year on fracture incidence was 
28% lower at 15 months and 56% lower at 2 years after the initial non-vertebral 
fracture.  Subgroup analyses according to baseline fracture indicated that the 
time-dependent effect was mainly driven by the effect in patients with a baseline 
hip fracture, since subsequent non-vertebral fracture incidence was 57-91% lower 
after a hip fracture in the FLS group, without differences after baseline major or 
minor non-vertebral fracture. The mortality rate was also lower in the FLS hos-
pital (-35%) compared to the no-FLS hospital after correction for age, sex and 
baseline fracture location. These results indicate that a FLS should be considered 
in patients with a recent fracture, especially after a recent hip or major fracture. 
In summary, we illustrated in part III that a FLS could have a beneficial effect 
on subsequent fracture incidence and mortality. We studied only patients with a 
recent non-vertebral fracture during a 2-year follow-up period and found a lower 
subsequent fracture incidence among patients evaluated and if needed treated 
at the FLS compared with both the historical control group and the no-FLS hos-
pital group. Longer follow up studies will be needed to explore the long-term 
effect of the FLS. 
generaL ConCLuSIon
Due to the ageing population and the burden of fractures on morbidity the 
health care costs increase exponentially. Secondary prevention of fractures is still 
a low priority for health care physicians, specialist and the general population. 
However, during the last decades progress has been made to identify the fracture 
patients and subsequent fracture incidence1, 12, 13. The implementation of a FLS 
contributed to increased awareness towards the fracture patient by medical 
specialists, such as (orthopedic) surgeon. A FLS is the bridge between the frac-
ture and the management of secondary fracture prevention. Possibly it could 
enhance patient’s medication adherence overtime by structured follow-up. Data 
on the effectiveness of a FLS are scarce. However, the research presented in this 
thesis as well as other data suggest that a FLS is effective in identifying most 
non-vertebral fracture patients at risk of subsequent fractures14. A recent study 
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into physical and cognitive functioning of people older than 90 years of age 
revealed that nowadays more people are living to older ages with better overall 
functioning15. Moreover, during the next two decades approximately 450 million 
people will reach retirement age, so the time has come to make FLS available for 
all older people suffering fractures throughout the world16. 
The International Osteoporosis Foundation (IOF) has launched an international 
Capture the Fracture Campaign in 2012 to promote secondary fracture preven-
tion by facilitating the implementation of FLSs17, 18. This website informs, as well 
as guides health care professionals to implement their own FLS and, furthermore, 
provides a platform for the global sharing of existing programs, resources about 
FLS and local implementation strategies17. A recent publication by the Ameri-
can Society for Bone and Mineral Research (ASBMR) entitled “Making the first 
fracture the last” showed the striking efforts health care professionals are trying 
to make to reduce subsequent fracture incidence in fragility fracture patients19. 
Similar initiatives are ongoing in collaboration of the European League against 
rheumatism (EULAR) with the European Federation of National Associations of 
Orthopaedics and Traumatology (EFORT)20. 
In 2005, the total direct cost of osteoporotic fractures in Europe was €32 billon per 
year, and is expected to rise to €37 billion by the year 202521. The cost-effectiveness 
of FLS for secondary prevention of fractures is another issue concerning the ini-
tiation of FLSs throughout the world. In the Netherlands, visits of patients at the 
outpatient clinic, as well as bone mineral density measurement are covered by 
health care insurance. Cost-effectiveness analyses based on fracture risk reduc-
tion assumptions indicate that FLSs could be cost-effective in fragility fracture 
patients for prevention of future fractures, but further prospective studies will 
be needed22, 23.
The prevention of subsequent fractures is multifactorial. Possible factors con-
tributing to a reduction of the risk could be the attention of the fracture nurse 
towards the patient, treatment with anti-osteoporosis medication, vitamin D and 
calcium supplements and fa ll prevention. The mechanisms by which mortality is 
reduced are still unclear and seem to be multifactorial and probably related to 
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extra skeletal effects of bisphosphonates or calcium and vitamin D or other still 
unclear mechanisms10. 
At the FLS the fracture nurse is the key figure in the assessment of fracture 
patients. They inquire into bone- and fall- related risk factors, previous medical 
history and arrange bone mineral density and laboratory tests. The leading goal 
is attempting to diminish possible reversible risk factors and to evaluate and 
treat the adverse risk factors, if applicable and to thereby reduce subsequent 
fractures and mortality. 
In conclusion, the results of this thesis suggest that the implementation of a 
FLS is clinically important, possibly leading to a lower subsequent fracture risk 
and mortality.
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Samenvatting en conclusies
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Op het gebied van fractuurbehandeling is er de laatste jaren een substantiële 
progressie geweest in het identificeren en herkennen van hoog risico patiënten 
voor een nieuwe fractuur. Hierbij is er ook een toenemende mate van bewijs dat 
een toegewijde en gespecialiseerde osteoporoseverpleegkundige, gesupervi-
seerd door (orthopedisch) chirurgen, rheumatologen en/of endocrinologen, 
zorgt voor het integreren van osteoporose- en valrichtlijnen in de “Fracture 
Liaison Service” (=Osteoporose Poli) (FLS). 
In dit proefschrift hebben we onderzoek gedaan bij patiënten met een re-
cente niet-wervelfractuur naar de timing en de risicofactoren voor een nieuwe, 
opeenvolgende niet-wervel fractuur en overlijden. Ook hebben we het nieuwe 
fractuurrisico en overlijdensrisico vergeleken in patiënten die behandeld zijn 
voor en na de implementatie van de Osteoporose Poli. 
deeL 1  nIeuWe oPeenVoLgende FraCTuur InCIdenTIe In 
PaTIënTen MeT een reCenTe nIeT-WerVeLFraCTuur
Het eerste doel van dit proefschrift was om de nieuwe, opeenvolgende fractuur 
incidentie te evalueren in patiënten met een recente niet-wervel fractuur. Hier-
voor hebben we in hoofdstuk 2 retrospectief een cohort van fractuurpatiënten 
van 50 jaar en ouder onderzocht. Allen hadden een recente niet-wervelfractuur. 
Het absolute risico voor een nieuwe, opeenvolgende niet-wervel fractuur bin-
nen 5 jaar was 17.6%. Hogere leeftijd was een significante risicofactor voor het 
optreden van een nieuwe, opeenvolgende niet-wervelfractuur (Figuur 1). Het ab-
soluut risico op overlijden was 32.3%. Significante risicofactoren voor overlijden 
waren hogere leeftijd, mannelijk geslacht en een initiële majeure fractuur (heup, 
bekken, multipele ribfracturen, proximale tibia/humerus en distale femurfrac-
tuur). Ook het hebben van een nieuwe, opeenvolgende niet-wervelfractuur was 
een significante risicofactor op overlijden binnen 5 jaar follow-up.
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Mortaliteit en fracturen na initiële heup of hand/voet 
fractuur (5 jr follow-up) 
9% 
8% 
27% 56% 
1ste heup fractuur (n=469) 
2nd fracture,
alive
2nd fracture,
died
Alive, no 2nd
fracture
Died, no 2nd
fracture
15% 
3% 
74% 
8% 
1ste hand/voet fractuur (n=263) 
Absoluut fractuur risico 
Allen: 
      17%           18% 
        Overlevenden: 
       40%           20% 
Figuur 1.
NIeuwe opeenvolgende fractuurincidentie en mortaliteit ingedeeld naar baseline fractuurlokatie
Verder vonden we ook een tijdsgerelateerd effect: het risico op een nieuwe, 
opeenvolgende fractuur, alsmede overlijden, was het hoogst direct na de 
niet-wervelfractuur. Na multivariabele analyses zagen we dat patiënten met 
een mineure fractuur een gelijkwaardig risico op een nieuwe, opeenvolgende 
niet-wervelfractuur hadden vergeleken met patiënten met een initiële majeure 
fractuur. Echter het risico op overlijden was wel hoger in de groep patiënten 
met een initiële majeure fractuur vergeleken met patiënten met een initiële 
mineure fractuur. Vanuit klinisch oogpunt gezien wijzen deze resultaten erop dat 
fractuurpreventie overwogen zou moeten worden na alle niet-wervelfracturen, 
en meteen gestart zou moeten na de initiële niet-wervelfractuur. Echter, er is nog 
steeds uitgebreid onderzoek nodig om te evalueren welke reversibele factoren 
gecorrigeerd kunnen worden om nieuwe, opeenvolgende niet-wervelfracturen 
en overlijden te voorkomen. 
In hoofdstuk 3, werd een overzicht verricht naar studies die zich toespitsen op 
de tijd en timing van nieuwe, opeenvolgende fracturen. Het Relatieve Risico (RR) 
van fracturen is verdubbeld na een fractuur, echter deze meta-analyse kon geen 
uitspraak doen over de timing van deze fracturen omdat deze studies nog niet 
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beschikbaar waren ten tijde van de geïncludeerde onderzoeken1. Onderzoeken 
die wel het tijdseffect tussen het onstaan van fracturen bestudeerden vonden 
een clustering van fracturen over de tijd, bijvoorbeeld het risico op een opeen-
volgende nieuwe fractuur is het hoogst het eerste jaar na de initiële fractuur en 
neemt af in de tijd na een fractuur. Dit is te zien bij herhaalde radiologische en 
klinische wervelfracturen, herhaalde heupfracturen en herhaalde laagenerge-
tische fracturen. Ook na een klinische wervelfractuur of heupfractuur werd dit 
tijdseffect gevonden. 
De resultaten van het onderzoek bij postmenopauzale vrouwen in Zuid-
Nederland toonde dat het risico voor een initiële fractuur 1% per jaar bedraagt en 
het opeenvolgende, nieuwe fractuur risico het hoogst was binnen het eerste jaar 
na de initiële fractuur (absoluut risico (AR): 6%) en dit daalde gestaag gedurende 
de jaren (AR over 20 jaar: 40%). Als men alleen keek naar de patiënten met een 
nieuwe, opeenvolgende fractuur zag men dat 23% van al deze fracturen optra-
den binnen het eerste jaar na de fractuur, binnen 5 jaar was dit 54%. Echter, na 15 
jaar was het risico op een nieuwe, opeenvolgende fractuur niet langer hoger dan 
het initiële fractuurrisico (Figuur 2)2. 
f acturen. Ook na een klinische wervelfractuur of heupfractuur werd dit tijdseffect 
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Figuur 2 
Clustering van fracturen in de tijd, met name in de eerste jaren 
 
Deze clustering van fracturen over de tijd toont aan dat men aandacht moet hebben voor de 
fractuurpatiënt meteen na de fractuur om een nieuwe, opeenvolgende fractuur te 
voorkomen. Wanneer men overweegt antiosteoporose medicijnen te starten, zou dit 
gebaseerd moeten zijn op basis van bewezen effect op korte termijn. 
 
Samenvattend tonen de resultaten van deel 1 van dit proefschrift dat binnen 5 jaar follow-
up bijna 1 op 5 patiënten met een recente niet-wervelfractuur een nieuwe, opeenvolgende 
fractuur oplopen. In overeenstemming met de recente literatuur traden de meeste nieuwe, 
opeenvolgende fracturen op binnen het 1ste jaar na de initiële fractuur. Mortaliteit was ook 
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Clustering van fracturen in de tijd, met name in de eerste jaren
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Deze clustering van fracturen over de tijd toont aan dat men aandacht moet 
hebben voor de fractuurpatiënt meteen na de fractuur om een nieuwe, opeen-
volgende fractuur te voorkomen. Wanneer men overweegt antiosteoporose me-
dicijnen te starten, zou dit gebaseerd moeten zijn op basis van bewezen effect 
op korte termijn.
Samenvattend tonen de resultaten van deel I van dit proefschrift dat binnen 5 
jaar follow-up bijna 1 op 5 patiënten met een recente niet-wervelfractuur een 
nieuwe, opeenvolgende fractuur oplopen. In overeenstemming met de recente 
literatuur traden de meeste nieuwe, opeenvolgende fracturen op binnen het 1ste 
jaar na de initiële fractuur. Mortaliteit was ook het hoogst binnen 1 jaar na de 
initiële fractuur. Om het risico op een nieuwe fractuur te verminderen is hierdoor 
onmiddellijke actie na de initiële fractuur vereist.
deeL 2 rISICo eVaLuaTIe oP de FraCTure LIaISon SerVICe
Het tweede doel van deze thesis was het evalueren van het implementeren van 
richtlijnen met betrekking tot osteoporose en vallen op de Fracture Liaison Ser-
vice door een gespecialiseerde fractuurverpleegkundige. Systematische aanpak 
van fractuurpatiënten op een FLS leidt tot verhoging van de identificatie van 
risicopatiënten3-5.
In hoofdstuk 4 hebben we de risicofactoren geanalyseerd in patiënten met een 
recente niet-wervelfractuur gedurende 2 jaar follow-up. De hypothese was dat 
patiënten met een initiële niet-wervelfractuur met bot- en valgerelateerde risi-
cofactoren een hoger risico hadden op een nieuwe, opeenvolgende fractuur en 
overlijden ondanks dat ze val- en fractuurpreventie kregen overeenkomstig de 
Nederlandse osteoporose en valpreventie richtlijnen6-8. Van alle geïncludeerde 
patiënten, had 51% tenminste één botgerelateerde risicofactor en 60% had 
tenminste één valgerelateerde risicofactor. Univariabele Cox regressie analyse 
toonde een 99% hoger risico op een nieuwe opeenvolgende fractuur bij patiën-
ten met de combinatie van bot- en valgerelateerde risicofactoren in vergelijking 
met alle andere patiënten. In multivariabele analyse (met leeftijd, geslacht en 
initiële fractuurlokatie geincludeerd) was deze tendens ook zichtbaar, echter het 
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was niet statistisch significant. We vonden ook een tijdseffect in patiënten met de 
combinatie van risicofactoren vergeleken met patiënten met alleen een botgere-
lateerde risicofactor. Meteen na de initiële fractuur tot 8 maanden hierna hebben 
patiënten met de combinatie van bot- en valgerelateerde risicofactoren een ho-
ger risico op een nieuwe, opeenvolgende fractuur. Echter een nieuw onderzoek 
met meer events is nodig om deze data te bevestigen. In univariabele analyse 
hadden patiënten met de combinatie van bot- en valgerelateerde risicofactoren 
een significant hoger risico op een nieuwe, opeenvolgende fractuur in vergelij-
king met patiënten met alleen valgerelateerde risicofactoren (Hazard Ratio (HR) 
2.41; 95% Confidentie Interval (CI) 1.06-6.46). Echter dit was niet significant in 
de multivariabele analyse. Deze data laten zien dat, ondanks dat alle patiënten 
waren geëvalueerd op de FLS, patiënten met een combinatie van bot- en val-
gerelateerde risicofactoren nog steeds een hoog fractuurrisico hebben op korte 
termijn. Er werd geen verschil gevonden tussen de patiënten met betrekking 
tot mortaliteit tijdens de 2 jaar follow-up. Mogelijke verklaringen hiervoor zijn 
dat het totale aantal overlijdens lag was (weinig events) of de behandeling met 
bisfosfonaten zijn. Bisfosfonaten zouden mogelijk mortaliteit reduceren, echter 
het exacte mechanism hierachter is nog onduidelijk. Mogelijk komt het door het 
effect op nieuwe, opeenvolgende fracturen of het effect op het lichaam buiten 
het skelet9-11.
Een evaluatie van meerdere FLS identificeerde verschillen en overeenkomsten 
in de uitvoering van op evidentie gebaseerde geneeskunde (“evidence-based”) 
en prevalentie van klinische risicofactoren. Dit kan ook helpen bij het opsporen 
van sterktes en zwakheden van richtlijnen en de implementatie hiervan. 
In hoofdstuk 5 was het doel om overeenkomsten en verschillen in de uit-
voering van 5 FLSs in Nederland te analyseren en daarbij de prevalentie van 
klinische risicofactoren te identificeren in deze groep. Onze hypothese was dat 
de FLSs patiënten selecteerden op basis van de geldende richtlijn osteoporose 
en vallen van het Kwaliteitsinstituut voor de Zorg (CBO)7. In totaal werden er 7199 
patiënten van 50 jaar en ouder met een recente niet-wervelfractuur prospectief 
gevolgd tijdens een periode van 39-58 maanden. Van deze 7199 
patiënten waren 76.7% vrouwen en de gemiddelde leeftijd was 66.7 jaar. 
Er was een significant verschil tussen de gerapporteerde prevalentie van de 
klinische risicofactoren tussen de verschillende FLSs. De variabiliteit tussen de 
gerapporteerde prevalenties van klinische risicofactoren werd uitgedrukt in 
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relatief risico (RR) en varieerde tussen 1.7 (eerdere wervelfractuur) tot 37.0 (glu-
cocorticoïd gebruik). We concludeerden uit deze data dat een gespecialiseerde 
osteoporoseverpleegkundige een central rol speelde in het identificeren van 
fractuurpatiënten voor het evalueren van risicofactoren voor nieuwe, opeen-
volgende fracturen en het organiseren van secundaire fractuurpreventie onder 
supervisie van een traumachirurg, orthopeed, endocrinoloog of rheumatoloog. 
We vonden ook dat er opvallend veel verschil is in de prevalentie van klinische 
risicofactoren en valrisico factoren in de gescreende fractuurpopulatie. Dit 
impliceert dat preventie strategieën om nieuwe, opeenvolgende fracturen te 
voorkomen vooral toegespitst moeten zijn op botdichtheid, klinische risicofac-
toren voor osteoporose en valrisicofactoren. Mogelijk zijn er ook verschillen in 
het voorkomen van risicofactoren tussen verschillende type fracturen. 
Als conclusie van deel II van deze thesis zagen we dat bij patiënten met een 
recente niet-wervelfractuur, die geëvalueerd en behandeld zijn op de FLS, 51% 
tenminste een botgerelateerde risicofactor had en 60% tenminste een valgere-
lateerde risicofactor. Patiënten met de combinatie van beiden hadden een 99% 
hoger risico op een nieuwe, opeenvolgende fractuur binnen twee jaar na hun 
initiële fractuur.  Er werd ook een tijdsafhankelijk effect waargenomen bij patiën-
ten met de combinatie van risicofactoren vergeleken met patiënten met alleen 
een botgerelateerde risicofactor met betrekking tot een nieuwe, opeenvolgende 
fractuur. Bij de evaluatie van de 5 FLSs in Nederland vonden we dat een gespeci-
aliseerde osteoporoseverpleegkundige een centrale rol speelt in de polikliniek. 
De veronderstelling dat alle ziekenhuizen patiënten strict selecteren op basis van 
de richtlijn osteoporose en fractuurpreventie van het Kwaliteitsinstituut voor de 
Zorg (CBO) is waarschijnlijk onjuist, aangezien we verschillen vonden in pati-
entselectie, klinische risicofactoren en prevalentie van klinische risicofactoren. 
Dit impliceert dat er meer concrete en gestandaardiseerde richtlijnen moeten 
komen om fractuurpatiënten in de dagelijkse praktijk te evalueren. 
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deeL 3 FraCTure LIaISon SerVICe: rISICo reduCTIe? 
Het derde doel van deze thesis was te onderzoeken of het implementeren van 
een FLS het risico op een nieuwe, opeenvolgende fractuur en overlijden zou 
kunnen verminderen. 
In hoofdstuk 6 hebben we op een prospectieve wijze patiënten van 50 jaar en 
ouder met een recente niet wervelfractuur die behandeld waren op de FLS in het 
Maastricht Universitair Medisch Centrum (MUMC) geïncludeerd. We hebben dit 
cohort vergeleken met een retrospectief cohort van fractuurpatiënten die be-
handeld waren in hetzelfde ziekenhuis voordat er een FLS was (pre-post analyse). 
In deze studie kwam naar voren dat implementatie van de osteoporose en val-
preventie richtlijnen geassocieerd was met een significant lagere incidentie van 
nieuwe, opeenvolgende niet-wervelfracturen met 35% binnen twee jaar en voor 
overlijden was dit 33% lager6, 7. De lagere incidentie van nieuwe, opeenvolgende 
fracturen is waarschijnlijk multifactorieel van origine, inclusief begeleiding, meer 
aandacht vanuit de patiënt met betrekking tot het ziektebeeld, calcium en vita-
mine D supplementen, antiosteoporose medicatie en valpreventie maatregelen. 
De afname in mortaliteit kan maar voor een gedeelte worden verklaard door het 
lagere nieuwe, opeenvolgende fractuurincidentie, zoals bij anderen ook naar 
voren is gekomen11. Dit suggereert dat postfractuur behandeling niet alleen een 
effect heeft op nieuwe, opeenvolgende fracturen maar ook op andere nadelige 
uitkomsten zoals mortaliteit. Verschillen in andere componenten van postfrac-
tuur behandeling (anesthesie, wondbehandeling) of verbeterde fractuurbehan-
deling door artsen die de richtlijnen toepassen, kunnen gerelateerd zijn aan de 
geobserveerde resultaten.
Daarom hebben we in hoofdstuk 7 de nieuwe, opeenvolgende fractuurinciden-
tie en mortaliteit geanalyseerd in een vooraf gespecificeerde groep van frac-
tuurpatiënten. We hebben alle patiënten met een recente niet-wervelfractuur 
tussen 2004-2006 geïncludeerd die behandeld waren in een ziekenhuis met en 
een ziekenhuis zonder FLS. In het niet-FLS ziekenhuis werd alleen de normale 
fractuurbehandeling toegepast met als doel fractuurheling. In het ziekenhuis 
met een FLS ondergingen patiënten een Dual-energy X-ray Absorptiometry scan 
(DXA-scan) en een bloedonderzoek. In totaal warden er 1412 patiënten gezien in 
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het ziekenhuis met een FLS en 1910 in het ziekenhuis zonder FLS. Patiënten die 
warden behandeld in het ziekenhuis met een FLS hadden een significante lagere, 
tijdsafhankelijke incidentie van nieuwe, opeenvolgende niet-wervelfracturen 
na correctie voor leeftijd, geslacht en baseline fractuurlokatie. Er werd geen 
significant verschil gevonden in het eerste jaar na de initiële fractuur, maar vanaf 
het tweede jaar was de fractuurincidentie 28% lager na 15 maanden follow-up 
en 56% na twee jaar follow-up. Subgroep analyses ingedeeld naar baseline frac-
tuurlokatie toonde een tijdsafhankelijk effect en dit was met name bij patiënten 
met een initiële heupfractuur. De nieuwe, opeenvolgende niet-wervelfractuur 
incidentie in deze patiënten was 57-91% lager in de groep van het ziekenhuis 
met een FLS vergeleken met de groep zonder FLS. Er waren geen verschillen 
gevonden in subgroup analyse bij patiënten met een initiële major of minor 
niet wervelfractuur. Mortaliteit was ook lager in de patiënten behandeld in het 
ziekenhuis met een FLS (-35%) na correctie voor leeftijd, geslacht en baseline 
fractuurlokatie. Deze resultaten tonen aan dat bij patiënten met een recente niet 
wervelfractuur behandeling in een ziekenhuis met een FLS overwogen dient te 
worden, met name na een recente heup of majeure fractuur. 
Samenvattend, in het IIIe deel van dit proefschrift toonden we aan dat een 
FLS geassocieerd is met een voordelig effect op de incidentie van een nieuwe, 
opeenvolgende fractuur en mortaliteit gedurende twee jaar follow-up. Verder 
vonden we bij patiënten geëvalueerd en behandeld in een ziekenhuis met een 
FLS een lagere incidentie van een nieuwe, opeenvolgende fractuur ten op zichte 
van zowel de historische controle groep als de groep patiënten behandeld in 
het ziekenhuis zonder FLS. Langere follow-up duur is nodig om deze resultaten 
verder te verifiëren.
aLgeMene ConCLuSIe
Gezien de vergrijzing met daarbijhorende stijging van het aantal fracturen in 
deze populatie zullen de ziektekosten de komende jaren exponentieel stijgen. 
Secundaire fractuurpreventie is een groeiende, maar nog steeds onvoldoende 
hoge prioriteit voor de arts, ziekenhuisspecialist of de algemene bevolking. 
Echter, tijdens de laatste decennia is er vooruitgang geboekt ten aanzien van 
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het identificeren van fractuurpatiënten en de nieuwe, opeenvolgende fractuur-
incidentie1, 12, 13. De implementatie van een FLS heeft bijgedragen aan een toene-
mende aandacht voor de fractuurpatiënten bij medisch specialisten, zoals een 
traumachirurg of orthopeed. Een FLS is de brug tussen de fractuur en secundaire 
fractuurpreventie. Mogelijk zou een FLS de therapietrouw van fractuurpatiënten 
kunnen verbeteren door middel van gestructureerde follow-up. Data over de 
effectiviteit van een FLS zijn schaars. Echter, zowel deze thesis alsmede andere 
data suggereren dat een FLS effectief kan zijn in het identificeren van patiënten 
met een recente niet wervelfractuur met een verhoogd risico op een nieuwe, 
opeenvolgende niet wervelfractuur14. Een recente studie met betrekking tot 
lichamelijk en cognitief functioneren in patiënten van 90 jaar en ouder, toonde 
dat deze ouderen tegenwoordig langer leven met een betere algehele condi-
tie15. Bovendien, de komende twee decennia zullen er 450 miljoen mensen de 
pensioengerechtigde leeftijd bereiken, dus de tijd is aangebroken om een FLS 
beschikbaar te maken voor alle ouderen met fracturen in de wereld16.
De International Osteoporosis Foundation (IOF) heeft in 2012 een “Capture the 
Fracture Campaign” op de markt gebracht om secundaire fractuurpreventie te 
stimuleren door de implementatie van een FLS te faciliteren17, 18. Deze website 
informeert en leidt zorgprofessionals om een eigen FLS te starten. Daarbij geeft 
het ook de mogelijkheid tot delen van bestaande fractuurprogramma’s en imple-
mentatie van FLS strategieën17. Een recente publicatie van de American Society 
for Bone and Mineral Research (ASBMR) getiteld “Making the first fracture the 
last” toonde de initiatieven van de zorgprofessionals om de nieuwe, opeenvol-
gende fractuurincidentie te reduceren in kwetsbare ouderen19.  Gelijkwaardige 
initiatieven komen vanuit de samenwerking tussen de European League against 
rheumatism (EULAR) en de European Federation of National Associations of 
Orthopaedics and Traumatology (EFORT)20.
In 2005 waren de totale directe kosten van osteoporotische fracturen in Europa 32 
miljard Euro per jaar. Men verwacht dat deze kosten zullen stijgen tot 37 miljard 
Euro in 202521. De kosteneffectiviteit van een FLS voor secundaire preventie van 
fracturen is een ander punt van aandacht als men een FLS wil implementeren 
in het ziekenhuis. In Nederland worden zowel de kosten met betrekking tot 
het bezoek van de FLS alsmede de DXA scan vergoed door de zorgverzekering. 
146 Chapter 9
Kosteneffectiviteitsstudies gebaseerd op fractuurreductie laten zien dat FLSs 
kosteneffectief zouden kunnen zijn in kwetsbare ouderen voor de preventie van 
nieuwe fracturen, echter meer onderzoek is noodzakelijk22, 23. 
De preventie van nieuwe, opeenvolgende fracturen is multifactorieel. Mogelijke 
factoren die zouden kunnen bijdrage aan het verlagen van het risico zijn de aan-
dacht van de osteoporoseverpleegkundige, antiosteoporose medicatie, calcium 
en vitamine D suppletie, valpreventie en follow-up. Het mechanisme waardoor 
mortaliteit gereduceerd is is nog onbekend en lijkt ook multifactorieel en moge-
lijk gerelateerd aan niet botgerelateerde effecten van bisfosfonaten of calcium 
en vitamine D of door andere nog onbekende mechanismen10. 
De osteoporoseverpleegkundige heeft een centrale rol in de beoordeling van 
fractuurpatiënten op de FLS. Die informeert naar bot- en valgerelateerde risico-
factoren, medische voorgeschiedenis en draagt zorg voor bloedonderzoek en 
DXA scan afspraak. Het hoofddoel is om de mogelijke reversibele risicofactoren te 
corrigeren en evaluatie en behandeling van de risicofactoren in de individuele pa-
tiënt om zodoende nieuwe, opeenvolgende fracturen en mortaliteit te verlagen. 
Dit opent de weg naar “treat-to-target’ en  geïndividualiseerde fractuurpreventie.
Concluderend, suggereren de resultaten van deze thesis dat de implementatie 
van een FLS klinisch van belang is omdat het geassocieerd is met een lager 
nieuw, opeenvolgend fractuurrisico en mortaliteit.
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